




GENOME-WIDE DISCOVERY AND ANNOTATION OF HUMAN ENHANCERS 
















A THESIS SUBMITTED FOR THE DEGREE OF 
 
DOCTOR OF PHILOSOPHY 
 
NUS GRADUATE SCHOOL FOR INTEGRATIVE SCIENCES AND ENGINEERING 
 











I hereby declare that this thesis is my original work and it has been written by me in its entirety.  
I have duly acknowledged all the sources of information which have been used in the thesis. 
 

































I would like to express sincere thanks to everyone who has helped me in one way or another 
throughout the past four years. Especially, I would like to thank my supervisors Dr Lim Bing and 
Dr Ruan Yijun, who have been a constant source of guidance, encouragement and inspiration. I 
would also like to express gratitude to my TAC members, Dr Axel Hillmer and Dr Melissa 
Fullwood, for their insightful feedback and suggestions. 
 
This work would not have been possible without contributions from a group of outstanding 
colleagues. Heartfelt thanks go to Mr Kyle Loh, Dr Ang Lay Teng, Dr Vibhor Kumar and Dr 
Shyam Prabhakar for their kind help for the endoderm project; Dr Li Guoliang, Dr Kuljeet Singh, 
Dr Zheng Meizhen, Dr Wang Ping, Ms Poh Huay Mei, Ms Joanne Lim, Ms Elaine Chew, Ms Sia 
Yee Yen and Ms Choi Yeen Hui for working with me on the ChIA-PET project; Dr Cathleen 
Teh and Dr Vladimir Korzh for their guidance in the zebrafish experiments. I also wish to 
acknowledge the GTB sequencing team, especially Ms Lee Yen Ling, for technical assistance 
and advice on next-generation sequencing. I also thank the GIS for hosting my PhD study and 
A*STAR for providing the scholarship and funding for this work.  
 
Last but not least I would like to thank my family members for being a constant source of love, 








TABLE OF CONTENTS 
DECLARATION ............................................................................................................................ II
ACKNOWLEDGEMENTS .......................................................................................................... III
TABLE OF CONTENTS .............................................................................................................. IV
SUMMARY ................................................................................................................................. VII
LIST OF TABLES ........................................................................................................................ IX
LIST OF FIGURES ....................................................................................................................... X
LIST OF ABBREVIATIONS ...................................................................................................... XII
CHAPTER 1 INTRODUCTION .................................................................................................... 1
1.1 The human genome sequence .............................................................................................. 1
1.2 Eukaryotic transcriptional machinery and transcriptional regulatory elements (TREs) ...... 2
1.2.1 Promoters ......................................................................................................................... 5
1.2.2 Enhancers ......................................................................................................................... 7
1.2.2.1 Enhancer architecture ................................................................................................... 8
1.2.2.2 Enhancer-promoter interactions ................................................................................. 12
1.2.2.3  Super-enhancers ......................................................................................................... 16
1.2.3 Silencers ......................................................................................................................... 18
1.2.4 Insulators ........................................................................................................................ 19
1.2.5 Locus Control Regions (LCRs) ...................................................................................... 21
1.3 Enhancers in development ................................................................................................. 22
1.4 TREs and enhancers in diseases ........................................................................................ 25
1.5 Genome-wide TRE mapping ............................................................................................. 29
1.5.1 Comparative genomics ................................................................................................... 31
1.5.2 Chromatin accessibility .................................................................................................. 33
1.5.3 Regulator binding ........................................................................................................... 35
1.5.4 Chromatin structure ........................................................................................................ 38
1.5.4.1 DNA methylation ....................................................................................................... 39
1.5.4.2 Histone modifications ................................................................................................. 41
1.6 Investigating higher-order chromatin organization ........................................................... 44
1.6.1 Chromosome Conformation Capture (3C) ..................................................................... 46
1.6.2 Circular chromosome conformation capture (4C) ......................................................... 48
1.6.3 Chromosome conformation capture carbon copy (5C) .................................................. 50
1.6.4 Hi-C ................................................................................................................................ 52




1.7 Embryonic endoderm development ................................................................................... 59
1.7.1 Multiple signaling levels regulate endoderm formation ................................................ 59
1.7.2 Endoderm patterning ...................................................................................................... 63
1.7.3 Endoderm induction from embryonic stem cells ........................................................... 66
1.8 Aim and objectives of thesis .............................................................................................. 68
CHAPTER 2 MATERIALS AND METHODS ........................................................................... 70
2.1 Cell culture ......................................................................................................................... 70
2.2 DE specification and anterioposterior patterning from hESCs .......................................... 71
2.3 RNA-seq and data analysis ................................................................................................ 72
2.4 Reverse-transcription quantitative-PCR ............................................................................ 73
2.5 Chromatin Immunoprecipitation (ChIP) and sequencing .................................................. 73
2.6 ChIP-seq data analysis ....................................................................................................... 75
2.7 Gene Set Enrichment Analysis (GSEA) ............................................................................ 76
2.8 Putative functional variant identification ........................................................................... 77
2.9 ChIA-PET library construction .......................................................................................... 78
2.10 Fluorescence In Situ Hybridization (FISH) ....................................................................... 79
2.11 RNAPII immunofluorescence staining combined with DNA FISH .................................. 80
2.12 Zebrafish enhancer reporter assay ..................................................................................... 81
CHAPTER 3 TRANSCRIPTIONAL AND EPIGENOMIC PROFILING DURING HUMAN 
ENDODERM DEVELOPMENT ................................................................................................. 83
3.1 Transcriptomic profiling of endoderm differentiation and patterning ............................... 83
3.2 Chromatin state profiling during endoderm formation ...................................................... 89
3.3 Promoter chromatin signatures for key regulators of endoderm differentiation ................ 93
3.4 Identification and epigenomic profiling of endoderm enhancers ...................................... 99
3.4.1 H3K27ac peak profiling identifies putative endoderm enhancers ............................... 100
3.4.2 Functional annotation of putative DE enhancers ......................................................... 102
3.5 Convergence of endoderm lineage-specifying TFs with TGF- signaling effectors for 
enhancer activation ..................................................................................................................... 104
3.5.1 Binding site analysis of putative DE enhancers ........................................................... 105
3.5.2 Association of putative DE enhancers with endoderm-specifying TFs ....................... 107
3.5.3 Coordination between TGF- effectors and EOMES for enhancer activation ............ 111
3.6 Endoderm enhancer priming ............................................................................................ 115
CHAPTER 4 ENHANCER DISCOVERY, ANNOTATION AND VALIDATION DURING 
ENDODERM PATTERNING .................................................................................................... 119




4.2 Functional annotation of enhancers ................................................................................. 122
4.2.1 Gene ontology and RNA expression analysis .............................................................. 122
4.2.2 Motif analysis of cell-type-specific enhancers ............................................................. 124
4.3 In vivo validation using a transgenic zebrafish model ..................................................... 126
4.4 Identification of a putative causative variant for ulcerative colitis .................................. 132
4.5 Risk locus target gene identification ................................................................................ 140
CHAPTER 5 ANALYSIS OF GLOBAL CHROMATIN INTERACTIONS IN 
TRANSCRIPTION CONTROL ................................................................................................. 143
5.1 RNAPII ChIA-PET library construction in K562 cells ................................................... 143
5.2 Distinct models of RNAPII-associated chromatin interactions ....................................... 145
5.3 Validation of chromatin interactions ............................................................................... 149
5.4 Enhancer-promoter interactions and disease-associated loci ........................................... 152
CHAPTER 6 CONCLUDING REMARKS................................................................................ 155
6.1 Endoderm enhancer discovery ......................................................................................... 155
6.2 ChIA-PET analysis of global chromatin interactions ...................................................... 159
REFERENCES ........................................................................................................................... 163
PUBLICATIONS DURING THE COURSE OF THIS STUDY ............................................... 196
APPENDIX I - OLIGONUCLEOTIDE SEQUENCES USED IN THIS STUDY .................... 197
APPENDIX II – BAC PROBES USED FOR DNA-FISH ......................................................... 199


















The complex, spatiotemporal gene expression patterns characteristic of multicellular organisms 
are controlled by sequence-specific cis-regulatory elements distributed throughout the genome.  
Among the different classes of elements, enhancers are recognized as key drivers of cell-type 
specific transcription programs, serving as an integrative binding platform for both lineage-
specific TFs and external signaling effector TFs. Due to this central role in gene regulation, 
disruption of enhancer function can lead to disease, and much interests have been focused on 
enhancer discovery and annotation in model cell lines (Bernstein et al., 2012). Despite these 
efforts, our understanding of enhancer activation dynamics, especially during embryonic 
development, remains incomplete. The annotation of all enhancers during cell differentiation and 
lineage commitment will help us dissect the complex patterns of developmental gene expression 
and understand the basis of gene dysregulation resulting in disease.  
 
The endoderm is the inner germ layer of the embryo which gives rise to the epithelial lining of 
the digestive and respiratory system, as well as components of the liver, pancreas, thyroid and 
thymus. Despite the physiological importance of these organs, relatively little is known about 
how endoderm progenitor cells give rise to all differentiated derivatives. To begin addressing this 
knowledge gap, we employed an in vitro endoderm differentiation model for transcriptome and 
epigenome profiling. Our transcriptome profiling of endoderm and its derivatives at defined 
developmental stages provided a valuable resource for the investigation of novel markers during 
lineage specification. Epigenomic and functional annotation of these enhancers further revealed 
the coordination between lineage-specifying TFs and signaling effectors for endoderm 




demonstrated the importance of these enhancer catalogs in facilitating the identification of causal 
variants of complex diseases relevant to endoderm organs. 
 
One defining characteristic of enhancers is expression regulation through a distance-independent 
manner, which confounds target gene identification and enhancer functionalization. Active 
enhancers are recognized to regulate gene expression through physical interactions with their 
target loci through the looping-out of intervening DNA sequences. To map global enhancer-
promoter interactions, I was involved in a large-scale ChIA-PET study, focusing on the general 
transcription factor RNAPII in multiple human cell types. This work not only revealed 
widespread cell-specific enhancer-promoter and promoter-promoter interactions, but also 
identified interactions involving disease-associated regulatory elements with their target genes.  
 
In sum, the enhancer repertoire uncovered in this work represents a valuable resource for the 
study of human endoderm formation and patterning. In addition to elements associated with 
known endoderm genes, we have predicted thousands of developmental enhancers whose 
regulatory functions were previously unknown. Our work on chromatin organization in human 
cells have also revealed previously unappreciated organizational complexity between regulatory 
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 CHAPTER 1 INTRODUCTION 
1.1 The human genome sequence 
The completion of the initial human genome sequence in 2001 represented a significant 
milestone in biology, human genetics and biomedical research (Lander et al., 2001; McPherson 
et al., 2001). Subsequent refinement and analyses of the draft sequence led to a comprehensive 
identification and mapping of 20,000 – 25,000 protein-coding genes (Consortium, 2004), 
signaling the beginning of an era of “omics” revolution from the traditional gene-centric 
paradigm. Equipped with this extensive catalogue, genetics researchers now face immense 
challenges in understanding the functions of these genes and their products, as well as their 
regulation and coordination at a cellular and organismal level. An added layer of complexity 
originated from the presence of vast stretches of poorly characterized, non-coding genomic 
regions within which protein-coding regions (1.9% of entire human genome) reside (Lander et 
al., 2001). The systematic identification of all functional elements in the human genome 
represented a crucial requisite for comprehensive understanding of the spatial and temporal 
expression patterns for all identified genes, as well as the basis for altered gene expression during 










1.2 Eukaryotic transcriptional machinery and transcriptional regulatory elements 
(TREs) 
Transcription of eukaryotic genes is dependent on three known classes of DNA-binding proteins, 
namely basic TFs, activators, and coactivators. Prior to each round of transcription, more than 30 
basic TFs, consisting of RNAPII and a variety of accessory factors, including TFIIA, TFIIB, 
TFIID, TFIIE, TFIIF and TFIIH, assemble on the core promoter as a Pre-initiation Complex 
(PIC), constituting the “basal transcription machinery” (Conaway and Conaway, 1993; 
Murakami et al., 2013). On its own, the PIC initiates low levels of basal transcriptional activity, 
while full transcription require the presence of sequence-specific activator TFs. These activators 
can be classified by their DNA-binding domains, which may include basic leucine zipper (bZIP), 
homeobox, forkhead or helix-loop-helix (HLH) domains (Pabo and Sauer, 1992). Activator 
function is mediated by a transcription activation module, which is thought to facilitate PIC 
formation through protein-protein interactions with basic TFs (Orphanides et al., 1996). One 
other mechanism for activator function involves coactivator recruitment through protein-protein 
interactions. Coactivators exist as large complexes and modulate activator function through 
interactions with the basic transcriptional machinery (i.e. Mediator coactivator complex) (Malik 
and Roeder, 2000) or through chromatin remodeling systems (i.e. SWI/SNF complex) (Neely et 
al., 1999).  
 
Components of the eukaryotic transcription machinery mediate gene expression by RNAPII 
through binding to specific nucleotide sequences called TREs. These elements include promoters 
and gene-distal elements such as enhancers, silencers, insulators and locus control regions (Fig 




harbor sequence motifs for activator TFs. The physical and functional properties of each of these 
































Figure 1.1 Transcriptional regulatory elements in eukaryotic genomes (Maston et al., 2006) 
TREs can be generally classified as promoter/promoter-proximal or distal element. These 



















Core promoters are located at the transcriptional start site (TSS) of genes. They are required and 
sufficient for transcription initiation by RNAPII through assembly of the PIC. Although 
considered as a single class of regulatory elements, core promoters are structurally and 
functionally diverse, harboring different types of Core Promoter Elements (CPEs), including the 
TATA box, Initiator element (Inr), Downstream Promoter Element (DPE), Downstream Core 
Element (DCE), Motif Ten Element (MTE), TFIIB-Recognition Element (BRE) and CpG islands 
(Kadonaga, 2012). The diversity of CPEs has been proposed to provide combinatorial regulation 
of transcription initiation, increasing the number of possible gene expression patterns in complex 
organisms (Gershenzon and Ioshikhes, 2005; Smale and Kadonaga, 2003). Sequence analyses 
revealed that CPEs are not universal across promoters – a large number of functional core 
promoters lack any of these known CPEs, suggesting the existence of other CPEs which are yet 
to be discovered (Hartmann et al., 2013). 
 
Located up to several hundred base pairs upstream of the core promoters are the proximal 
promoters. These elements have been demonstrated to regulate transcription through binding of 
specific TFs (Hock et al., 2004; Landry et al., 2005). A functional link between proximal 
promoters and distal enhancers was first suggested by the finding that these two classes of 
elements activate transcription through binding to the same ‘general’ activation protein domains 
(Seipel et al., 1992). In one example, promoter deletion studies showed that a proximal promoter 
of the glucagon receptor gene functioned as a cis-acting enhancer and regulates constitutive gene 
expression (Geiger et al., 2001). Besides harboring intrinsic enhancer activities, proximal 




(Grzeskowiak et al., 2000; Vorachek et al., 2000; Wood et al., 1998). Due to these properties, 
proximal promoters are considered functionally indistinguishable from enhancers. Indeed, recent 
computational analyses revealed sequence features of proximal promoters which reliably 
























Transcriptional enhancers are short, non-coding regulatory elements responsible for activating 
target gene expression during differentiation and development (Visel et al., 2009a). Enhancer 
activity was first documented over 30 years ago within a region of the SV40 virus genome which, 
when cloned and introduced into a human cell line, increased transcription of a reporter gene by 
several hundred folds (Banerji et al., 1981). Subsequent to this seminal discovery, the first 
mammalian enhancers, driving cell-type specific expression of the Ig heavy chain gene, were 
identified (Banerji et al., 1983; Gillies et al., 1983). Due to a unique property of enhancers to 
function independent of the distance to their target gene as well as the underlying chromatin 
context, enhancers can be ‘hijacked’ through an enhancer trap, allowing unbiased identification 
and screenings for spatial enhancer activities (Korzh, 2007). Leveraging on this, enhancer trap 
assays in Drosophila demonstrated that distal cis-regulatory elements drive spatial and temporal 
gene expression patterns during development (O’Kane and Gehring, 1987). More recently, 
studies employing high-throughput genomic profiling of TF-binding, histone modifications and 
open chromatin suggested the presence of hundreds of thousands of enhancers across multiple 
cell types, often residing far from their target promoters (Bernstein et al., 2012; Ernst et al., 2011; 
May et al., 2011; Rada-Iglesias et al., 2011). These genome-wide observations led to the current 
view of enhancer activation as a highly dynamic and cell-type-specific process, and raised 
several key mechanistic questions regarding how enhancers function in TF binding and how 







1.2.2.1 Enhancer architecture 
A general feature of enhancers is the enrichment of clusters of functional TF binding sites in 
various combinations (Arnone and Davidson, 1997; Berman et al., 2002; Gotea et al., 2010; 
Levy et al., 2001), which is a critical molecular mechanism to ensure robustness of TF 
recruitment for tight gene expression regulation, while preventing unwanted activation through 
randomly occurring binding sites. Detailed studies of enhancer architecture in Drosophila and 
zebrafish have revealed the existence of regulatory modules, each containing one or several TF 
binding sites, within each enhancer (Arnosti et al., 1996; Kulkarni and Arnosti, 2003; Liu and 
Posakony, 2012; Rastegar et al., 2008). These regulatory modules function as separate functional 
units, occupy flexible positions within an enhancer and can independently regulate gene 
expression. These observations have led to the ‘billboard’ model, where enhancers function as 
‘information display’ platforms with the overall functional output of an enhancer depends on net 
sum of all modules contained within (Fig 1.2A). This model, established through independent 
studies of individual enhancers, was further supported by a massively parallel reporter assay 
which tested almost 5,000 synthetic enhancers (Smith et al., 2013). The organizational flexibility 
underlying the billboard model has been suggested to confer evolutionary flexibility to enhancers, 
as demonstrated by sequence and binding site divergence of the even-skipped enhancer between 
the Sepsidae and Drosophilidae species (Hare et al., 2008), and may explain the weak sequence 
conservation of certain human enhancers (Blow et al., 2010).  
 
Despite strong experimental support for flexible motif positioning within a large number of 
enhancers, strict motif positioning, including spacing, order and orientation, has been observed in 




(IFN-) enhancer (Thanos and Maniatis, 1995), where small sequence changes to individual 
motifs, or the spacing between them, is sufficient to impair binding of all eight known factors 
binding the enhancer (Fig 1.2B) (Panne et al., 2007). The striking sequence constraint at this 
locus led to an alternative model, the ‘enhanceosome’ model of enhancer architecture (Merika 
and Thanos, 2001), where individual TFs assemble in a cooperative  and highly ordered manner 
relative to each other, forming unique, stable complexes or ‘enhanceosomes’. This model can 
explain why presence of individual TFs do not activate IFN- transcription (Thanos and Maniatis, 
1995). The requirement for cooperative TF binding leads to a sharp, “all-or-none” activation 
effect, characteristic of rapid biological processes such as the immune response. Indeed, 
enhanceosomes assembly have been reported for the activation of other immune-related genes, 
such as interleukin-6 and interleukin-2 receptor  (Vanden Berghe et al., 1999; John et al., 1995).  
Unlike the enhancers functioning under the ‘billboard’ model, the strict sequence constraints at 
enhanceosome binding sites make these enhancers more susceptible to inactivating mutations 
(Panne et al., 2004, 2007).  
 
Accumulating evidence suggests that both the billboard and enhanceosome models may 
represent two extreme ends of a spectrum of architectural diversity, and that no generalizable 
motif rules exist when large numbers of enhancers are examined. For example, during cardiac 
specification in Drosophila, five cardiac developmental TFs co-bind bind and activate heart 
enhancers in the absence of any consistent motif patterns (Junion et al., 2012). In the absence of 
one TF, all remaining TFs failed to mediate enhancer activation, emphasizing the importance of 




protein-protein interactions in determining overall enhancer activities, beyond that of a linear 
nucleotide-based code.  
 
The increasing availability of high-throughput reporter assays (Levo and Segal, 2014) enabling 
quantitative output measurement of large numbers of enhancers may further challenge these 
existing models founded on a principled understanding of enhancer function. The current 
research focus on enhancer architecture lies in gaining further mechanistic understanding beyond 
the description of specific enhancers. This is exemplified by current research focus moving from 
simple models of DNA binding codes to higher levels of protein DNA interactions, including 
protein side-chain flexibility, DNA shape-readout, docking geometries and protein allosteric 

























Figure 1.2 Two models of enhancer function (Arnosti and Kulkarni, 2005)  
A) In the billboard model, regulatory modules within enhancers function independently and 
occupy flexible positions. Enhancer cooperativity is not necessary, and net enhancer output 
depends on net effect of individual interactions between TFs (grey circles) and repressors (black 
boxes) and the basal transcription machinery, resulting in transcription activation (top) or 
repression (bottom). 
B) In the enhanceosome model, TFs (grey ovals and circles) bind to a strictly defined motif 
structure, where all TFs assemble cooperatively for gene activation. Disruption of motif 
sequence, or displacement of a single motif resulting in lack of a single TF, causes the enhancer 











1.2.2.2 Enhancer-promoter interactions 
The highly organized TF binding patterns on enhancers raised further questions regarding how 
binding information is relayed to target promoters, and several models have been proposed to 
address this question (Fig 1.3). Binding of sequence-specific TFs have been proposed to induce 
the transcription complex to ‘track’ from the distal enhancer, through small steps along the 
intervening DNA, until it encounter its target promoter (Bulger and Groudine, 2011). This model 
has only been tested on a few enhancers and requires more detailed validation. Focused 
investigations at several independent loci suggest that enhancers mediate long-range chromatin 
loops through various mechanisms which lead to the juxtaposition of enhancer and promoter 
elements. Through chromatin conformation capture (3C) and gene knockdown assays, these 
studies have demonstrated critical roles for lineage-specific TFs in mediating chromatin loop 
formation and subsequent target gene expression (Yun et al., 2014; Zhang et al., 2013a; Zhou et 
al., 2013). A novel insight in enhancer function was illustrated by a recent finding that enhancer 
looping mediated by the LIM domain-binding protein 1 (LDB1) may simultaneously enhance 
target gene expression and repress other target genes at the level of promoter pausing in pituitary 
corticotrope cells (Zhang et al., 2015).  
 
An alternative enhancer–promoter looping mechanism involving chromatin architectural proteins 
was supported through the genome-wide observation that CTCF binding sites significantly 
overlap enhancer elements (Shen et al., 2012). This mechanism was subsequently supported by 
findings of CTCF-mediated chromatin looping at multiple individual gene loci  (Eldholm et al., 
2014; Gosalia et al., 2014; Majumder and Boss, 2010), as well as the PCDH gene cluster 




directly recruits TATA-binding protein-associated factor 3 (TAF3) to promoter distal sites for 
DNA looping suggests that CTCF may directly interact with the core transcription machinery 
complex to tether enhancers to their target promoters (Liu et al., 2011). 
 
A third mechanism through which enhancers mediate chromatin looping involves the 
transcription of non-coding RNAs (ncRNA) on enhancers, termed enhancer RNAs (eRNAs) 
(Kim et al., 2010; Wang et al., 2011). Although eRNAs are transcribed from a large proportion 
of enhancers, the mechanistic details of their functions, if any, remained unclear. Antisense 
oligonucleotide blockage of eRNAs at both the NRIP1 and GREB1 loci resulted in disruption of 
enhancer-promoter interactions with concomitant reduction in target gene expression (Li et al., 
2013). Similarly, knockdown of the enhancer-assocation ncRNA CCAT1-L resulted in reduced 
interaction frequency between CCAT1-L locus and decreased MYC transcription in colorectal 
cancer cells (Xiang et al., 2014), strengthening support for a role of eRNAs in physically 
tethering enhancer-promoter loops. Collectively these studies highlight the versatility of 
enhancers in harnessing TFs, architectural proteins and ncRNAs as mechanistic tools to transmit 
regulatory information to their target genes.   
 
Enhancer regulation of gene expression may occur at different stages of transcription, including 
transcription initiation, elongation or termination. The direct involvement of components of the 
general transcription machinery in enhancer-promoter loop formation suggests that regulation 
occurs at the level of transcription initiation (Koch et al., 2011; Liu et al., 2011; Ren et al., 2011). 
In support, the mediator complex co-occupies ESC enhancers with the pluripotency factors 




with cohesin (Kagey et al., 2010). More recent work have revealed a novel role of enhancer 
loops in regulating promoter-proximal pause release and led to a new class of enhancers termed 
‘anti-pause’ enhancers (Liu et al., 2013). Looping of these enhancers result in activation of the P-
TEFb complex and release of RNAPII for elongation. Global chromatin contact maps during 
Drosophila embryogenesis further revealed that enhancer-promoter contacts remained similar 
across developmental stages and frequently associated with paused RNAPII, suggesting release 
of paused polymerase as a key transcriptional mechanism facilitating rapid activation of 
developmental genes (Ghavi-helm et al., 2014). These studies provided further mechanistic 



























Figure 1.3 Proposed model for enhancer function (Williamson et al., 2011) 
Activator TFs binding to enhancers may recruit additional co-activators, which reorganize 
chromatin along the intervening region facilitating tracking of the transcription complex towards 
the target genes (bottom left). Alternatively, spatial colocalization between enhancers and target 














1.2.2.3  Super-enhancers 
A set of studies focusing on enhancer discovery through chromatin modifications and TF binding 
proposed a unique class of TREs termed ‘super-enhancers’ (Hnisz et al., 2013; Lovén et al., 2013; 
Whyte et al., 2013). These studies suggest that a small subset of enhancers act as key regulators 
of cell fate, cell-type-specific gene expression and important drivers of oncogenic progression. 
Super-enhancers tend to span large genomic distances and generally have a median size of an 
order of magnitude larger than normal enhancers. Super-enhancers can be identified through the 
‘stitching’ of adjacent enhancers and assessment of Med1 enrichment levels (Whyte et al., 2013). 
Since the initial proposal of the super-enhancer concept, various publications have employed 
differing defining criteria for super-enhancers. For example, Med1, H3K27ac and the master TF 
MyoD have each been used for super-enhancer identification (Hnisz et al., 2013; Lovén et al., 
2013). To date, the only consistent feature of super-enhancers is the exceptionally high TF or 
histone modification enrichment levels revealed by ChIP-seq assays.  
 
Despite the lack of a clear criterion for super-enhancer identification, the current definitions have 
revealed several important properties of these elements. Genomic profiles of lineage-specific TFs 
and H3K27ac have revealed widespread prevalence of super-enhancers in over 90 different cell 
types and tissues (Hnisz et al., 2013; Whyte et al., 2013). In a broad range of cancer cells, super-
enhancers were found to be specifically enriched at multiple oncogenes (Hnisz et al., 2013; 
Lovén et al., 2013). Notably, binding of the BRD4 transcriptional coactivator at super-enhancers 
and expression of associated oncogenes were specifically impaired by Brd4 inhibition, 
highlighting a potential mechanism in which bromodomain inhibitors achieve cancer therapeutic 




enriched for disease-associated variants. This was illustrated for super-enhancers found in human 
brain tissues and immune cells, which were associated with SNPs associated with Alzheimer’s 
disease and rheumatoid arthritis respectively (Hnisz et al., 2013)    
 
Given that super-enhancers are identified through the clustering of individual enhancers into a 
single broad element, it is unclear whether the functions observed for super-enhancers are in fact 
a reflection of individual enhancers used to define super-enhancers. The assessment of 
cooperativity between individual enhancers may reveal whether super-enhancers function more 
than the sum of its parts. To date, this possibility has not been conclusively tested and remains a 
major goal of the super-enhancer concept. One confounding technical problem lies in the 
difficulty to accurately quantify small differences in TF binding through ChIP-seq datasets (Park 
et al., 2013; Teytelman et al., 2013). Despite contrasting views on whether super-enhancers 
provide any novel insights on enhancer function, blockage of super-enhancer function through 
inhibition of general TF or coactivator binding led to disruption of oncogene expression ion 
tumor cells, highlight super-enhancers as a potential therapeutic target for selective inhibition of 












Silencers, as the name suggests, repress gene transcription. Like enhancers, silencers are 
sequence-specific elements and function in a distance- and orientation-independent manner, 
although location-dependent silencers have been reported (Dong and Lim, 1996; Moffat et al., 
1996). Silencers can be found on promoters, intergenic regions, or within introns. They function 
through the recruitment of repressive TFs called repressors, which exert a negative influence on 
transcription through several mechanisms. Repressors targeted to the core promoter can directly 
repress RNAPII through post-translational modifications (Hengartner et al., 1998), or indirectly 
through blockage of basal TF binding (Li and Manley, 1998). Repressors can also antagonize 
activator binding: the BCL-6 repressor blocks its target promoters through competition with 
activator TFs for proximal promoter binding (Harris et al., 2005). The mechanisms of repressor 
function are broadened through the recruitment of co-repressor complexes (Privalsky, 2004; 
Reynolds et al., 2013). These complexes, such as the Polycomb Group proteins, repress 
transcription through chromatin compaction by modifying histones (Srinivasan and Atchison, 
2004). More recent genome-wide analyses of repressor and co-repressor binding sites revealed 
widespread binding of repressors on actively transcribed regions of the genome (Wang et al., 
2009), raising the possibility that repressors may in fact function as activators which prime or 










The specificity of the long-range regulatory effects of enhancers and silencers are enforced by a 
unique class of elements, called insulators, which partition the genome into discreet domains of 
expression (Valenzuela and Kamakaka, 2006). Insulators function either as barrier elements, 
preventing the spread of repressive chromatin domains, or enhancer blockers, disrupting 
enhancer-promoter communication (Fig 1.4). Sequences involved in insulator function typically 
resided between compact and de-condensed regions of the chromosome, and were traditionally 
identified through functional tests involving the integration of reporter constructs into cell lines 
or transgenic animals (Chung et al., 1993; Kellum and Schedl, 1991). These efforts led to the 
identification of several insulator binding proteins in Drosophila, such as BEAF, Zw5 and CTCF 
(Gaszner et al., 1999; Roy et al., 2007; Zhao et al., 1995). In contrast, the only Drosophila 
insulator protein with a vertebrate orthologue is CTCF (Bell et al., 1999). Contrary to its classical 
role as an insulator protein, recent 5C analyses revealed CTCF enrichment on looping 
interactions between active distal enhancers and promoters, and that 79% of all distal enhancer-
promoter interactions are not blocked by intervening CTCF binding sites (Sanyal et al., 2012). At 
individual gene loci, CTCF has also been demonstrated to regulate complex gene clusters with 
distal regulatory elements (Golan-Mashiach et al., 2012; Xu et al., 2011). Collectively, these 
studies are leading to an emerging concept of CTCF as an architectural protein, establishing 
genome topology and mediating interactions between regulatory elements and their target genes 

















Figure 1.4 Mechanisms of insulator function (Valenzuela and Kamakaka, 2006) 
Barrier insulators prevent the spread of heterochromatin regions, protecting target promoters 















1.2.5 Locus Control Regions (LCRs) 
LCRs are composite regulatory elements which regulate a gene cluster or locus, directing 
physiological and tissue-specific gene expression. (Li, Kenneth R., X. Fang, 2002). LCRs consist 
of multiple cis-acting elements, including enhancers, insulators and silencers, which can be 
identified by a cluster of DNase-hypersensitive (HS) sites. Each HS site may exhibit variable TF 
binding, histone modifications and chromatin interactions (Kim et al., 2012), resulting in variable 
effects on gene expression between each element. The overall function of an LCR depends on 
the collective activities of individual HS sites, although most LCRs exhibit strong enhancer 
activity. LCR-associated elements can also operate in an additive or synergistic manner (Engel 
and Tanimoto, 2000). The different combinations of elements thus confer LCRs great diversity 
and properties in driving tissue-specific expression. 
  
The -globin LCR was the first LCR to be identified, consisting of a 16kb genomic span with 5 
HS sites driving erythrocyte-specific expression (Grosveld et al., 1987). Since then, LCRs have 
been discovered as key drivers for a large number of mammalian gene clusters, including the T 
cell receptor, apolipoprotein and immunoglobulin loci (Li, Kenneth R., X. Fang, 2002). Because 
of their central role in transcriptional control, mutations in LCRs have been implicated in human 









1.3 Enhancers in development  
Enhancers are the most abundant and variable type of TREs between different cell types, and are 
recognized as the primary drivers of cell-type specific gene expression patterns (Heintzman et al., 
2009; Parker et al., 2013; Xi et al., 2007). The dynamics of such cell-type specific gene 
regulation is particularly evident during early embryonic development, where gene expression 
patterns and cell fate decision outcomes depend on the integration of multiple signaling 
pathways. Because the signaling effectors of these pathways occupy enhancers together with 
cell-specific master regulatory TFs (Trompouki et al., 2011), enhancers have been considered 
“information integration hubs” (Buecker and Wysocka, 2012), where external signals, regulatory 
TFs and genomic sequence information converge to establish the complex, dynamic expression 
patterns during development.  
 
During early embryonic development, pluripotent and multipotent stem cells are exposed to 
multiple extrinsic signaling pathways, which guide these progenitors to undergo self-renewal or 
specify them towards specific cell fates (Pera and Tam, 2010). These signaling pathways evoke 
different cellular responses not only through induction of tissue-specific TF expression, but also 
by differential enhancer activation. For example, during hepatocyte differentiation, Hippo 
signaling mediates HNF4A and FOXA2 to bind and activate distinct sets of enhancers, allowing 
these master liver TFs to express different genes and fulfill distinct roles during cell 
differentiation and organ development (Alder et al., 2014). Such developmental gene regulation 
is also evident at the tissue and organ level, where distinct sets of master TFs in different 





In order for enhancer activation to occur in a timely and dynamic manner during development, 
enhancer specification occurs early during development before their target genes are expressed. 
Early observations through in vivo footprinting analyses revealed that FoxA and GATA factors, 
required for Alb1 gene expression in liver, bound the Alb1 enhancer in endoderm cells and were 
required for subsequent Alb1 enhancer function (Bossard and Zaret, 1998; Gualdi et al., 1996; 
Liu et al., 1991). Because chromatin occupancy by these factors preceded other TFs in liver, they 
were termed ‘pioneer factors’. Not only were pioneer factors characterized by the timing of DNA 
binding, they were able to bind condensed chromatin. Subsequently, pioneer factors in other cell 
types were discovered, such as PU.1 and RUNX1 in B cells, and FoxD3, Sox2 and Sp1 in ES 
cells (Raghu Ram and Meshorer, 2009). Pioneer factor binding on enhancers may facilitate rapid 
transcriptional activation by reducing the number of binding events required later in development 
(Fig 1.5). Alternatively, pioneer factors may also actively organize the local chromatin to 
facilitate binding of other regulatory TFs. For example, the pioneer factors FoxA1, GATA-4 and 
TFE3 can generate local DNase hypersensitivity in chromatin (Cirillo et al., 2002; Ishii et al., 
2004). In addition to pioneer factor binding, an additional property of many developmental 
enhancers is that they are held in a primed state, marked by H3K4me1 and H3K37me3, but 
devoid of H3K27ac, in ES cells (Rada-Iglesias et al., 2011). Upon differentiation, these ‘poised’ 
enhancers acquire H3K27ac and were associated with gene activation. Subsequently, H3K9me3 
was also identified as a mark of poised enhancers independent of H3K27me3. A poised enhancer 
state thus allows for timely expression of key developmental genes upon signaling and 













Figure 1.5 Active and passive roles of pioneer factors (Zaret and Carroll, 2011) 
Pioneer factors may function passively, facilitating enhancer activation through prior binding 
which reduces the number of binding events required subsequently. Alternatively, pioneer 
factors can actively remodel the underlying chromatin structure, indirectly allowing other 
















1.4 TREs and enhancers in diseases 
Given the pivotal role of TREs in developmental gene control, it is not surprising that a large 
number of mutations in TREs have been linked to human diseases. According to data compiled 
by the Human Gene Mutation Database (www.hgmd.cf.ac.uk), a total of 3,024 regulatory 
mutations have been identified, as of Oct 2014, which underlie or are associated with human 
inherited diseases. These documented mutations are mainly found on promoters, and their 
corresponding target genes and underlying defects are well-defined. Table 1 illustrates a list of 
classic Mendelian disorders resulting from TRE mutations. Such mutations disrupt basic TF or 
activator binding which are required for transcription through RNAPII, resulting in significant 
changes in expression levels of a single gene. Although most mutations increase disease risk 
through reduction of transcription, some mutations may also increase gene transcription. For 
example, mutation of a COLIA1 regulatory element increases TF binding affinity and COLIA1 
transcription, resulting in an altered ratio of transcribed collagen chains leading to reduced bone 
mineral density (Grant et al., 1996). Besides promoters, several mutations in distal enhancers 
were identified to be associated with disease phenotypes. For example, the blood disorder  
-thalassemia, a result of dysregulation of the -globin gene, can be caused by translocations 
which remove a distal enhancer required for high-level expression of the -globin gene in 
erythroblasts (Driscoll et al., 1989) (Table 1). In another example, point mutations or 
translocations of an upstream enhancer of the sonic hedgehog (SHH) gene, a regulator of limb 
and brain development, was found to be associated with inherited preaxial polydactyly (Lettice et 





In contrast to monogenic Mendelian diseases, many common human disorders exhibit a more 
complex inheritance pattern, and disease susceptibility depends on the net effect of interactions 
between multiple genes and may be influenced by environmental factors. To understand the 
genetic changes underlying common disease susceptibility, it is useful to examine common 
genetic variation, such as Single Nucleotide Polymorphisms (SNPs), to detect associations 
between variants and the disorder. Such variants can be identified through genomewide 
association studies (GWASs) which employ high-density SNP arrays to scan for SNPs which are 
statistically associated with the trait of interest. To date, GWASs have identified hundreds of 
common variants statistically correlated with various traits and diseases (Welter et al., 2014). 
Because SNPs probed in these studies are designed to capture genome linkage disequilibrium 
structure, trait-associated SNPs are more likely to tag actual risk loci rather than being causal 
themselves. More than 90% of these variants are found on noncoding regions and are enriched in 
DHSs (Maurano et al., 2012) (Fig 1.6), suggesting that causal variants may disrupt regulatory 
element function. Large-scale epigenomic profiling further revealed a correlation of GWAS 
variants with the enhancer marks H3K4me1, H3K27ac and eRNA (Akhtar-Zaidi et al., 2012; 
Ernst et al., 2011; Farh et al., 2015), suggesting that the disruption of enhancer function and 
dysregulation of the relevant target gene(s) may underlie disease predisposition. In support, fine-
mapping of various diseases-associated loci, including coronary artery disease (Harismendy et al., 
2011), breast cancer  (French et al., 2013; Meyer et al., 2013) and obesity (Smemo et al., 2014) 
identified functional variants disrupting enhancer TF binding and expression of target genes. The 
functional annotation of all genomic TREs, especially enhancers, is expected to shed light on the 





Table 1. TREs associated with human diseases 
TRE Disease Gene affected Reference 
Core promoter -thalassemia HBB (Antonarakis et al., 1984) 
    
Proximal promoter Familial hypercholesterolemia LDLR (Mozas et al., 2002) 
 
Hemophilia B F9 (Reitsma et al., 1988) 
 
Pyruvate kinase deficiency PKLR (Manco et al., 2000) 
 
Charcot-Marie-Tooth disease GJB1 (Wang et al., 2000) 
    
Enhancer Aniridia PAX6 (Lauderdale et al., 2000) 
 
Preaxial polydactyl SHH (Lettice et al., 2003) 
 
Van Buchem disease SOST (Loots et al., 2005) 
 
X-linked deafness POU3F4 (Naranjo et al., 2010) 
    
Insulator Hereditary spherocytosis ANK1 (Gallagher et al., 2010) 
    
Silencer Asthma TGF- (Hobbs et al., 1998) 
 
Facioscapulohumeral muscular 
dystrophy 4q35 genes (Gabellini et al., 2002) 
    
LCR -thalassemia HBB (Driscoll et al., 1989) 
 























Figure 1.6 Genomic distribution of GWAS SNPs (Maurano et al., 2012) 
(A) Distribution of GWAS SNPs according to localization on various genomic features, 
















1.5 Genome-wide TRE mapping  
To functionalize TREs and understand how they are coordinated for gene regulation, as well as 
the genetic basis of TRE-associated diseases, it is essential to identify and annotate these 
elements on a genome-wide scale. Unlike TREs at core/proximal promoters, distal TREs are 
distributed throughout the vast regions of non-coding DNA far from their target genes. In 
addition, these elements tend to be small and degenerate, and exhibit variable sequence 
conservation, confounding their identification and annotation. In the past decade, several 
international consortia, such as ENCODE and the Roadmap Epigenomics Project (Fig 1.7A), 
have been set up for collaborative epigenome mapping through resource- and data-sharing. The 
rapid development of NGS technologies and data analysis tools have greatly increased the scope 
and precision through which nucleotide sequences could be interrogated. As a result, many novel 
biochemical assays, such as DNase-seq, ChIP-seq and ChIA-PET, were developed and adopted 
by multiple research labs to leverage on the capabilities of NGS platforms (Fig 1.7B). Using 
these assays and model cell lines, TREs in 1% of the human genome were mapped in 2007 
(Consortium, 2007), and a comprehensive catalogue of TREs in the entire genome was 
completed in 2012 (Bernstein et al., 2012). These high-throughput genomic mapping tools are 










Figure 1.7 Genome-wide functional element identification.  
(A) Multiple large-scale international consortia were established to focus on epigenomic 
mapping. (B) High-throughput experimental techniques employed for the identification of 









1.5.1 Comparative genomics 
Given their central role in mediating gene expression, TREs tend to be evolutionarily conserved 
due to functional selection. Hence, in principle, TREs can be identified through sequence 
comparisons between genomes of different organisms and determining regions of high homology 
(Loots et al., 2000). Such sequence comparisons involve the generation of alignments between 
orthologous sequence pairs using bioinformatics approaches, taking into account inherent 
variations such as DNA rearrangements, insertions, deletions, and repeating elements. BLAST 
(Altschul et al., 1990) represented one of the first alignment tools for pairwise sequence 
comparison, and has since evolved into a family of related programs for different types of input 
sequences (Loots, 2008). To overcome the limitations of BLAST in alignment of large genomic 
regions, newer tools, such as PipMaker and Mulan, were developed which can handle multiple 
sequence comparisons up to genome-scale size. Visualization of large scale alignment data were 
facilitated by various web-based database interfaces, such as the UCSC and Ensembl genome 
browsers, which allow visual navigation along entire genomes. Comparative sequence alignment 
between human, mouse and fish genomes have been leveraged for genome-wide identification of 
human TREs which function as tissue-specific enhancers (Pennacchio et al., 2006; Visel et al., 
2008) and silencers (Ochi et al., 2012). 
 
One limitation of the comparative genomics approach is the underlying assumption that 
functional elements under evolutionary constraint exhibit higher similarity, which may not 
always be true. In a large-scale deletion of over 1,000 constrained elements in mice, no obvious 
impact on phenotype was observed, suggesting that not all conserved elements are functional 




at the HBB locus, where well-characterized HBB regulatory elements do not exhibit sequence 
alignment in all the organisms examined (King et al., 2005). On a genome-wide scale, ChIP-seq 
of mouse heart tissue identified functional enhancers which are poorly conserved (Blow et al., 
2010). A second limitation of comparative genomics is the lack of functional details of the 
identified TREs beyond sequence conservation. Collectively, the limitations of comparative 






















1.5.2 Chromatin accessibility 
Eukaryotic genomes are organized as chromatin, a complex of DNA and histone proteins tightly 
wound into repeating units called “nucleosomes” (Kornberg and Lorch, 1999). Native chromatin, 
with a condensed nucleosomal structure, occludes DNA-regulatory protein interactions. Regions 
of chromatin harboring TREs must therefore undergo structural remodeling to increase 
accessibility of the underlying DNA to regulatory factors. Such physical differences in chromatin 
accessibility can be used as a proxy for TRE mapping, as nucleosome-free regions exhibit 
pronounced sensitivity to nuclease digestion compared to native chromatin (Gross and Garrard, 
1988). Enzymatic cleavage of chromatin using DNase I or micrococcal nuclease (MNase) can be 
coupled with high-throughput sequencing (DNase- and MNase-seq) (Boyle et al., 2008; Schones 
et al., 2008) to achieve high resolution genome-wide mapping of open chromatin structure. An 
alternative approach, Formaldehyde-Assisted Isolation of Regulatory Elements-sequencing 
(FAIRE-seq), employs formaldehyde crosslinking and sequencing to identify open chromatin 
through depletion of histone-bound DNA (Gaulton et al., 2010; Giresi et al., 2007).  
 
By measuring chromatin accessibility in 125 cell and tissue types, a total of 2.9 million DNase-
hypersensitive sites (DHSs) have been identified in the human genome, of which ~ 970,000 sites 
were cell-type-specific (Thurman et al., 2012). The findings that these DHSs were highly 
correlated with TF binding signals, and that a majority (97.4%) of experimentally-validated cis-
regulatory elements were found within DHSs, highlighted chromatin accessibility profiling as a 
powerful tool for comprehensive mapping of regulatory elements. One limitation of DHS-
mapping is the large number (50 million) of cells needed (Song and Crawford, 2010), precluding 




ATAC-seq, was developed to leverage on the unique properties of Tn5 transposase for genome 
fragmentation and sequencing adaptor transposition into accessible chromatin regions for 
sequencing (Buenrostro et al., 2013). This assay negates multiple intermediate steps, such as gel 
purification and cross-link reversal, enabling mapping of open chromatin with as little as 500 
cells and within clinical timescales. However, like comparative genomics approaches, the lack of 
functional details for these accessible elements necessitated the integration of additional genomic 




















1.5.3 Regulator binding 
The gene regulatory function of TREs are typically mediated by TF binding, hence the 
identification of TF binding sites represents an alternative method for high-throughput TRE 
discovery. Among the first genomic technique developed for this purpose is DNA adenine 
methyltransferase (Dam) identification (DamID) (van Steensel and Henikoff, 2000). In this 
method, Dam is fused to the DNA-binding protein of interest, resulting in methylation of DNA 
loci bound by, or in proximity to the protein of interest. Genomic DNA is subsequently digested 
using methylation-sensitive restriction enzymes followed by ligation of universal adapters. 
Methylated fragments, representing molecular beacons for protein-bound loci, are then 
selectively amplified by PCR and detected through microarray hybridization. Using DamID, it is 
possible to detect indirect and transient binding interactions. However, this assay relies on 
average DNA methylation patterns over up to 24hrs (Vogel et al., 2007) and is unable to map TF 
binding changes and TRE activation in dynamic biological processes, such as embryonic 
development.  
 
An alternative method is ChIP-seq, where bound transcription factors or chromatin proteins are 
first covalently crosslinked to DNA. Following chromatin fragmentation, DNA fragments are 
enriched, through their bound proteins, in an immunoprecipitation step. These DNA fragments, 
representing genomic locations of the bound factor, are purified for adapter ligation and high-
throughput sequencing (Fig 1.8). Unlike DamID, ChIP-seq allows genome-wide quantification 
of all in vivo TF binding sites with high resolution and accuracy, making it possible to perform 
motif predictions to identify non-canonical TF motifs (Johnson et al., 2007). Furthermore, the 




time-course analysis of binding dynamics (Sandmann et al., 2007; Yáñez-Cuna et al., 2012). A 
significant improvement of the original ChIP-seq protocol was developed by incorporating an 
additional nuclease digestion step to trim out unbound and contaminating DNA from protein-
binding nucleotides (Rhee and Pugh, 2011). This refinement allowed ChIP-exo to achieve near 
single-nucleotide resolution of binding peaks with considerably lower false positive rates.  
 
ChIP-seq has been applied to map the binding profiles of more than 100 known TFs in over 70 
cell types, revealing hundreds of thousands of putative TREs (Bernstein et al., 2012). Depending 
on the TF targeted, ChIP-seq can be used to identify specific classes of TREs. For example, 
global mapping of the insulator protein CTCF revealed cell-type specific barrier insulator 
elements (Cuddapah et al., 2009), while profiling of the histone acetyltransferase p300 identified 
active, tissue-specific enhancers (Visel et al., 2009b). Although ChIP-seq can potentially identify 
all genomic loci bound by a TF, not all these bound sites are functional in regulating gene 
expression (Fisher et al., 2012; Li et al., 2008). Hence, TREs identified through regulator binding 
may include a large number of false positive elements, which may be eliminated through 





































1.5.4 Chromatin structure 
Beyond the primary nucleotide sequence, gene expression regulation by TREs also involves 
chemical and structural changes to DNA, commonly referred to as epigenetic modifications 
(Felsenfeld and Groudine, 2003). These modifications can be classified into two main categories: 
direct methylation of DNA cytosine residues, and post-translational modification of nucleosomal 
histones. Functionally, these non-genetic changes regulate chromatin packaging as well as 
genome interpretation by the transcriptional machinery, thus defining TRE identity and function. 
As such, global profiling of epigenetic modifications represents a powerful method for TRE 
discovery and annotation. Recently, long noncoding RNAs (lncRNAs) have been demonstrated 
as key regulators of gene expression and are considered a new class of epigenetic modulators. 
















1.5.4.1 DNA methylation 
DNA methylation typically occurs on the cytosine residues of CpG dinucleotides in vertebrates 
(Bird, 2002), and up to 70 – 80% of all CpG dinucleotides are methylated in humans (Ehrlich et 
al., 1982). Unmethylated CpG dinucleotides often form clusters, known as CpG islands, at the 5’ 
ends of genes (Bird, 1987). The presence of a CpG methyl group can either promote or inhibit 
binding of transcriptional regulatory proteins, thereby influencing gene expression patterns. For 
example, methyl-CpG binding domain proteins specifically bind to methylated CpG 
dinucleotides, facilitating the recruitment of histone deacetylases for chromatin compaction and 
transcriptional repression (Bird, 2002; Hashimshony et al., 2003). Conversely, methylation of 
CTCF binding sites at the H19 locus abolished insulator recruitment, resulting in expression of 
the imprinted Igf2 gene (Bell and Felsenfeld, 2000). Due to its widespread effects on gene 
expression, DNA methylation have been implicated in diverse processes including X 
chromosome inactivation, carcinogenesis, development and aging (Das and Singal, 2004; Lister 
et al., 2013; Mohandas et al., 1981; Oliveira et al., 2012). 
 
Globally, DNA methylation can be profiled by coupling several biochemical assays with high-
throughput sequencing. The first method, bisulphite sequencing, involves bisulphite treatment of 
DNA to convert unmethylated cytosines to uracil (Clark et al., 1994), which is recognized as 
thymine after PCR amplification and sequencing. A second method involves restriction digestion 
of DNA, which typically occurs on unmethylated DNA (Bird and Southern, 1978). Alternatively, 
methylated DNA can be selectively isolated by affinity purification (Cross et al., 1994). The 
analysis of such genome-wide methylation profiles, or methylomes, revealed that DNA 




TF binding (Feldmann et al., 2013; Stadler et al., 2011). More specifically, these studies revealed 
that TF binding outside CpG islands is required to generate low-methylated regions (LMRs), 
which correspond to distal regulatory elements exhibiting cell-type specificity, DNase 
hypersensitivity and enhancer activities. Importantly, aberrant methylation profiles at these 
elements have been associated with gene dysregulation in cancer (Aran et al., 2013), suggesting 
that gene expression control by DNA methylation at distal TREs underlie changes in gene 




















1.5.4.2 Histone modifications 
In eukaryotic cells, DNA is folded into nucleosomes, or histone-DNA complexes which 
constitute a fundamental, repeating unit of chromatin. Each nucleosome consists of 147 bp of 
DNA wrapped around a histone octamer, consisting of two copies of each of the 4 core histones 
(H2A, H2B, H3, H4) (Kornberg, 1974). Each core histone consists of an N terminal tail which 
can be chemically modified, and more than 100 different posttranslational modifications have 
been identified on the amino-terminal tails, including acetylation, methylation, ubiquitylation 
and sumoylation (Kouzarides, 2007). Histone modifications play activating and repressive roles 
in transcription, and generally regulate gene expression through their effects on chromatin 
accessibility and protein recruitment, yet the detailed mechanisms and functions of a large 
number of these modifications are not well understood. Genome-wide surveys of histone 
modification localization has been recognized as an effective method to study their roles in 
transcription regulation, as well as facilitate detailed mechanistic studies on effects of their 
deposition and removal on gene expression. 
 
Extensive global profiling of histone modifications have been performed using ChIP-seq (Barski 
et al., 2007; Mikkelsen et al., 2007; Wang et al., 2008). These landmark studies provided a first 
glimpse into the complex patterns of modifications, known as the “histone code”, at key genomic 
features, such as promoters, transcribed gene bodies, enhancers and silenced chromatin (Fig 1.9). 
For example, H3K27ac is found on both active promoters and distal enhancers, while 
H3K27me3 generally marks repressed or heterochromatic regions (Fig 1.9). Subsequent efforts 
in epigenome mapping during development revealed a class of ‘poised’ enhancers which were 




on H3K27ac enrichment (Creyghton et al., 2010; Rada-Iglesias et al., 2011). The expanding 
repertoire of publicly available chromatin maps has facilitated computational efforts in 
integrative analyses. To systematically and comprehensively dissect the functions of the various 
histone modification combinations, chromatin states from nine human cell lines were segmented 
into regions of varying combinations using a multivariate hidden Markov model (Ernst et al., 
2011). Such integrative analyses of multiple chromatin marks, together with similar work 
performed on ENCODE chromatin data (Hoffman et al., 2013; Won et al., 2013), provide greater 
precision and reliability in TRE prediction and condense the large number of chromatin 
combinations into manageable sets of functional annotations. A key future direction will be to 
expand histone profiling to include more physiologically-relevant cell types, such as from 
normal and diseased tissues, to uncover the unique chromatin signatures underlying the different 

























Figure 1.9 Histone modifications mark functional genomic elements (Zhou et al., 2011) 
Promoters, gene bodies, enhancers, insulators, repressed genes. Histone modifications 















1.6 Investigating higher-order chromatin organization 
The concerted efforts in genome-wide profiling of open chromatin, TF binding sites and 
chromatin structure over the past few years have greatly facilitated the identification of hundreds 
of thousands of functional regulatory elements and genetic enhancers (Rivera and Ren, 2013; Xie 
et al., 2013; Zhu et al., 2013). However, these catalogues of epigenomic data are presented as 
two-dimensional, linear maps with no information linking regulatory elements to their target 
gene or loci. The discovery that eukaryotic enhancers can regulate their target genes over 
megabases of intervening DNA sequences (Lettice et al., 2003; Qin et al., 2004), together with 
the demonstration that specific DNA regulatory elements are capable of organizing chromatin 
into domains with distinct expression patterns (Kurukuti et al., 2006; Murrell et al., 2004), 
suggest a role of topological chromatin organization in transcription regulation. Not only so, 
defects in higher-order genome organization have also been implicated in gene misregulation 
leading to human diseases (Misteli, 2010). Hence, large-scale mappings of chromatin 
conformation and long-range chromatin interactions not only provide a 3D perspective of the 
genome, but can also inform about the role of chromatin in transcription regulation in health and 
disease, as well as aid in the functionalization of common disease risk loci. 
 
The past two decades has seen rapid development of various molecular and genomic methods for 
the investigation of chromatin organization. Among the first genomic technique developed is 
DNA adenine methyltransferase (Dam) identification (DamID) (van Steensel and Henikoff, 
2000). In principle, by fusing Dam to a chromatin-binding protein of interest, target DNA loci 
bound by, or in proximity to the chromatin protein, will be specifically methylated. Genomic 




ligation of universal adapters. Methylated fragments are then selectively amplified by PCR and 
detected through microarray hybridization. The DamID technique has been extensively applied 
in Drosophila to study chromatin interactions associated with heterochromatin components, 
various transcription factors, Polycomb complex proteins and nuclear lamina proteins at 
kilobase-pair resolution (Moorman et al., 2006; Pickersgill et al., 2006; van Steensel and 
Henikoff, 2000; Tolhuis et al., 2006). To study the remodeling of genome organization by 
nuclear lamins during differentiation, Peric Hupkes and colleagues applied DamID to map 
lamin-associated chromatin contacts in embryonic and terminally differentiated mouse cells, 
uncovering functional reorganization of hundreds of genes in single transcription units and large, 
multigene domains (Peric-Hupkes et al., 2010). As DamID relies on average DNA methylation 
patterns over up to 24 hrs as a readout of proximity (Vogel et al., 2007), it is unable to capture 
the highly fluid and dynamic changes of lamin scaffold organization previously reported in 
embryonic stem cells (Bhattacharya et al., 2009). The use of exogenous fusion proteins also 
precludes DamID experiments on endogenous proteins with native post-translational 
modifications, such as epigenetic histone signatures, which are intimately tied to chromatin 
spatial organization. DamID is therefore suitable for genome-wide analysis of chromatin contacts 










1.6.1 Chromosome Conformation Capture (3C) 
A major breakthrough in chromatin organization research resulted from the development of the 
Chromosome Conformation Capture (3C) assay and its subsequent variants (de Wit and de Laat, 
2012) (Fig 1.10). All 3C variants rely on the proximity ligation concept employed in the “nuclear 
ligation assay” developed in the Seyfred laboratory (Cullen et al., 1993). In 3C, cells are first 
fixed with formaldehyde to covalently link DNA with their associated proteins. Crosslinked 
chromatin is then cut using restriction endonucleases, generating chromatin complexes with 
protruding, sticky-ended DNA strands which are re-ligated under dilute conditions favoring 
intra-molecular ligations. Interaction frequencies between specific loci, represented by ligation 
junctions, are then semiquantitatively analyzed through agarose gel electrophoresis (Dekker et al., 
2002) or quantitatively through qPCR (Splinter et al., 2006; Vernimmen et al., 2007; Würtele 
and Chartrand, 2006). In both methods, restriction fragments are amplified using primers specific 
for predicted ligation junctions. Using this method, Dekker and colleagues constructed a 
population-averaged contact matrix of yeast chromsome 3, from which a 3D model was 
developed (Dekker et al., 2002). 3C was subsequently applied to study the -globin gene locus, 
uncovering multiple contacts between LCRs with the active -globin locus in mouse (Tolhuis et 
al., 2002), consistent with an independent RNA-TRAP analysis of the same locus (Carter et al., 
2002). These observations prompted Tolhuis and colleagues to propose that clustering of distal 
enhancers into an “Active Chromatin Hub” constitutes a key requirement for globin gene 
expression. Further work employing the 3C assay have demonstrated looping chromatin 
interactions involving insulator elements (Liu and Garrard, 2005), imprinting control regions 
(ICR) (Murrell et al., 2004) and trans-interactions from different chromosomes (Dhar et al., 2009; 




loci for target gene identification (Bauer et al., 2013; French et al., 2013; Zhang et al., 2012b), 

























1.6.2 Circular chromosome conformation capture (4C) 
To overcome the limitations of 3C in detecting widely-spaced and novel interactions, several 
related strategies, collective termed ‘4C’, have been developed to enable whole-genome 
identification of interaction sites associated with a genomic locus of choice (Lomvardas et al., 
2006; Simonis et al., 2006; Zhao et al., 2006). Regardless of the strategy, all 4C methods rely on 
the formation of a circular DNA template and inverse PCR using primers specific for a genomic 
locus of interest. Crosslinked chromatin is first cut with four-base cutting restriction enzyme and 
ligated as in 3C protocols. Subsequent crosslink reversal results in circular DNA molecules 
which are amenable to inverse PCR amplification. Amplicons representing interacting sites are 
identified through microarray hybridization or sequencing, revealing global chromatin 
interactions associated with the H19 ICR and the olfactory receptor enhancer. Frequent four-base 
cutters are preferred over six-base cutters as four-cutters generate smaller restriction fragments 
which provide higher resolution and are more reliably amplified by inverse PCR (Ohlsson and 
Göndör, 2007). Alternatively, a six-cutter can be used in the initial digestion followed by a four-
cutter digestion after proximity ligation and crosslink reversal to extract ligation junctions for 
circularization and inverse PCR (Simonis et al., 2006). Higher circularization efficiency is 
expected using the latter strategy, as reactions are performed on smaller, naked DNA instead of 
crosslinked DNA. The second digestion step also ensures that ligation junctions are not too large 
to be efficiently amplified by inverse PCR, which is possible when multiple DNA fragments are 
crosslinked and ligated. A modification of this two-step digestion strategy was employed by Ling 
et al. in their “Associated Chromosome Trap” (ACT) assay (Ling et al., 2006). Instead of 
circularization and inverse PCR amplification of interacting sequences, PCR adapters are ligated 




ACT assay demonstrated that imprinting control regions (ICRs) can physically colocalise with 
their target genes through interchromosomal interactions. Like 3C, 4C can be coupled with ChIP 
and a ChIP-4C technique, termed enhanced-4C (e4C), has been developed to study all 
transcriptional interactions associated with a locus of interest (Schoenfelder et al., 2009). 
Through RNAPII immunoprecipitation, proximity ligation and 4C analysis, a cluster of hundreds 
of transcribed loci were found to be associated with the mouse globin locus, with specific subsets 
of coassociated gene loci bound and coregulated by a lineage-specific TF, Klf1. To overcome 
some of the inherent limitations associated restriction digestion of chromatin, a sonication-based 
4C strategy was developed (Fullwood et al., 2010). Regardless of the exact strategy used, these 
studies collectively exemplified 4C as a versatile “one-versus-all” strategy for targeted dissection 
of global chromatin interaction. Indeed, 4C has been successfully applied to chart the cis-
regulatory circuitry at the FTO locus, unraveling the genetic targets of noncoding variation 














1.6.3 Chromosome conformation capture carbon copy (5C) 
5C is an adaptation of 3C for chromatin interaction analysis between multiple genomic elements 
in parallel. Following proximity ligation and crosslink reversal, 3C templates are subjected to 
ligation-mediated amplification (LMA) (Landegren et al., 1988) at high levels of primer 
multiplexing. Each primer pair, specific for one end of a restriction fragment, will anneal 
adjacent to one another at the targeted ligation junction and are subsequently ligated to form a 5C 
library. As each primer carry a universal 5’ end sequence, the 5C library can be amplified with a 
pair of universal primers. Ligation junctions can then be quantified using microarray or high-
throughput sequencing. Comprehensive 5C analyses of the -globin locus not only recapitulated 
known LCR interactions, but also revealed novel interactions between the LCR and the - and -
globin genes (Dostie et al., 2006). The 2D interactions maps generated by 5C can be represented 
in 3D using an iterative modeling approach, first demonstrated at the HoxA gene cluster to reveal 
chromatin dynamics during cellular differentiation (Fraser et al., 2009). Subsequent work 
combining 5C with an integrative structure determination platform (Alber et al., 2007) 
culminated in higher-resolution 3D models of the -globin domain, demonstrating the clustering 
of active genes into chromatin globules (Baù et al., 2011). This strategy was subsequently 
applied to uncovering the basic folding principles of a bacteria genome (Umbarger et al., 2011). 
Several inherent limitations preclude the use of 5C technology for modeling larger genomes. 
When measuring interaction frequencies over many Mbs in complex genomes, the large numbers 
of ligation junctions, coupled with high levels of multiplexing primers, confounds accurate 
ligation junction quantification. Although the use of universal primers in 5C largely avoids 
amplification efficiency issues present in 3C, annealing efficiencies of 5C primers can vary and 




consisting of numerous minimally-overlapping BAC clones, can be laborious for large genomes. 
5C is thus suited for comprehensive analyses of long range interactions within specific gene 

























Hi-C was developed in 2009 to leverage on the scale of massively parallel DNA sequencing 
technologies to address global chromatin interactions at a genome-wide scale. In Hi-C, 
crosslinked chromatin is fragmented through restriction digestion, leaving overhangs which are 
filled in with biotin-labeled nucleotides. Blunt-ended DNA fragments are ligated under dilute 
proximity ligation conditions and purified after crosslink reversal. DNA is further sheared and 
ligation junctions are pulled down using streptavidin beads. High throughput sequencing of 
ligation junctions following by reference genome mapping will identify interaction between all 
pairs of restriction fragments. Using this catalogue of interacting fragments, Lieberman et al 
constructed the first genome-wide matrix of chromatin contacts in human cells at Mb-scale, 
confirming known principles of genomic organization and revealing distinct spatial 
compartmentalization of open, gene-rich chromatin from inactive and closed domains 
(Lieberman-Aiden et al., 2009). These domains were proposed to be territorially organized in a 
highly compact, knot-free configuration within the nucleus. A subsequent Hi-C study using 
human and mouse cells revealed high pervasiveness and conservation of chromatin domains 
within and between species (Dixon et al., 2012), suggesting evolutionary conservation of 
topological domains as a structural feature of mammalian genomes. In Drosophila, a higher 
resolution (kilobase-pair-scale) Hi-C map has likewise uncovered distinct physical domains 
demarcating genomic activity (Sexton et al., 2012). Notably, analysis of Drosophila chromatin 
interactions at higher resolution (10-100 kb) suggests a hierarchical organization involving 
discrete physical chromatin modules, distinct from the fractal globule conformation proposed 





One variant of Hi-C has been independently developed to address chromosomal configurations 
in yeast (Duan et al., 2010). In this assay, ligation junctions are circularized following two 
restriction digestion steps as in 4C. A further restriction digestion step allows ligation of adapters 
containing an EcoP15I restriction site. Subsequent EcoP15I digestion releases paired-end tags for 
high throughput sequencing. This strategy was successfully applied to map global chromatin 
interactions at kb-resolution in yeast, leading to a proposed 3D model consistent with the Rabl-
orientation reported in yeast nuclei (Jin et al., 1998). A second strategy, tethered chromosome 
capture (TCC) (Kalhor et al., 2012), was developed to minimize random inter-complex ligations 
by immobilizing chromatin complexes on beads prior to proximity ligation. The improved 
sensitivity allowed the authors to define specific chromosomal regions and quantify their 
propensity to from interchromosomal interactions. 
 
The Hi-C assay can be combined with other genomic techniques to study the link between 
chromatin organization and specific biological processes. As discussed by Wijchers and 
colleague (Wijchers and de Laat, 2011) and substantiated by in silico analysis of human Hi-C 
data (Fudenberg et al., 2011), 3D genome organization may be the primary dictator of the targets 
of cancer-causing chromosomal recombination, suggesting that chromatin conformation directly 
reflects gene expression patterns underlying normal and diseased biological processes.  
Furthermore, by combining Hi-C with genome-wide translocation sequencing, it was 
demonstrated that a direct relationship exist between intra- and interchromosomal translocation 
loci and their proximity in spatial space (Chiarle et al., 2011; Zhang et al., 2012c). A further 
study subsequently revealed a direct relationship between Hi-C chromatin proximity maps and 




compartmentalization as a possible mechanism for regulating DNA replication. Collectively, 
these studies highlight the broad applicability of Hi-C with other genomic techniques to address 


















































1.6.5 Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET)  
The determination of 3D chromatin organizations represents an exciting first step towards 
complete functional annotation of the genome. To understand how DNA sequence and 
associated proteins specify genome organization, ChIA-PET was developed (Fullwood et al., 
2009). In this assay (Fig 1.11), crosslinked chromatin is sheared by sonication and enriched for 
specific protein factors through immunoprecipitation. Biotinylated half-linkers containing MmeI 
restriction sites are added to blunt-ended DNA fragments to facilitate proximity ligation. 
Following crosslink reversal, DNA fragments are restriction digested to release ligation junctions, 
which are isolated using streptavidin-coupled magnetic beads. Through PCR amplification, high-
throughput sequencing and reference genome mapping of ligation junctions, ChIA-PET allows 
the detection of DNA loci tethered together by the protein factor of interest and connected 
through proximity ligation. In a proof-of-concept study, ChIA-PET has been applied to analyze 
chromatin interactions associated with oestrogen receptor  in human breast adenocarcinoma 
cells (Fullwood et al., 2009). The identification of all ER-associated chromatin interactions 
allowed the mapping of an extensive network of intrachromosomal interactions involving gene 
promoters, suggesting a global mechanism through which ER organizes higher-order chromatin 
structure to direct target gene expression.  
 
The role of chromosomal organization in global transcriptional regulation was elucidated in a 
subsequent ChIA-PET study which mapped long-range chromatin interactions associated with 
RNA polymerase II (RNAPII) in five human cell lines (Li et al., 2012). Widespread promoter-
centered chromatin contacts were uncovered which further aggregated into multigene complexes, 




postulated “transcription factory” model (Cook, 1999). Furthermore, in an independent study of 
H3K4me2-associated chromatin interactions (Chepelev et al., 2012), a large proportion (56%) of 
interactions were formed between promoters exhibiting coexpression, suggesting that subnuclear 
chromatin organization provides a structural framework for transcription regulation. 
 
Insights into chromatin organization beyond the 30 nm fiber have been provided by the 
identification of various scaffolding proteins, such as SATB, CTCF, condensin  and the mediator 
complex (Cai et al., 2003; Gartenberg and Merkenschlager, 2008; Kagey et al., 2010; Phillips 
and Corces, 2009). Among these factors, CTCF has been recognized as the “master” regulator of 
chromatin architecture. ChIA-PET has been applied to map the CTCF chromatin interactome in 
mouse embryonic stem cells (Handoko et al., 2011), revealing novel intra- and interchromosomal 
interactions. Through association of CTCF-associated chromatin loops with their underlying 
epigenetic signatures, five distinct interaction domains were uncovered, each specifying a unique 
transcriptional status, suggesting interplay between architectural proteins and transcriptional 
machinery for functional chromatin compaction. An investigation of enhancer-promoter 
interactions through cohesin-associated chromosome structures further revealed that transcription 
of cell identity genes, driven by super-enhancers, are control by local chromosome structure 



































1.7 Embryonic endoderm development 
1.7.1 Multiple signaling levels regulate endoderm formation 
The definitive endoderm (DE) is one of the three primary germ layers which is formed during 
gastrulation (Lu et al., 2001). DE is a physiologically important germ layer as it gives rise to a 
diverse array of cell types, including epithelial cells of the digestive and respiratory systems, as 
well as multiple organs such as the liver, pancreas, thymus, thyroid and lungs. As a result of this 
versatility in organ specification, disruptions in endodermal organ functions lead to multiple 
human diseases afflicting millions of individuals each year. A thorough understanding of 
endoderm organ formation, from descriptive embryology, signaling pathways, transcription 
factor networks and cis-regulatory systems is needed to understand the genetic basis of human 
congenital diseases, as well as to facilitate efforts in endoderm tissue engineering for 
transplantation based therapies.   
 
Fate-mapping and embryological experiments in model organisms such as mouse, chick Xenopus 
and zebrafish have revealed the cellular aspects of endoderm emergence (Fig 1.12). Despite 
differences in morphological arrangements of the prospective germ layers, the underlying 
molecular pathways culminating in a primitive gut tube formation are highly conserved. In all 
amniote embryos, gastrulation begins when a cluster of cells at the posterior end of the epiblast 
ingress to form the primitive streak (PS), which marks the site of further cellular migration 
culminating in mesoderm and endoderm formation (Mikawa et al., 2004). Specifically, epiblast 
cells at the anterior end of the primitive streak transit through an “epithelial-mesenchymal” 
process and form the middle (mesoderm) or outer (definitive endoderm) layer of the gastrula 




by signals arising from the surrounding mesoderm, which specify the naïve endoderm to distinct 
foregut, midgut and hindgut domains (Zorn and Wells, 2009). These committed domains are 
further specified into various organ-specific lineages, ultimately contributing to the formation of 
organs along the anterior-posterior body axis, such as the esophagus, lungs, stomach, liver, 
pancreas and intestines (Grapin-Botton and Melton, 2000). 
 
In vivo genetic perturbation and explant studies have provided much insights into the extrinsic 
signals required for endoderm lineage specification (Zorn and Wells, 2009). The Nodal signaling 
pathway is central to body axes specification as well as mesoderm and endoderm formation in 
frog, zebrafish, mouse and chick (Schier, 2003). Nodal signaling ligands belong to the TFB 
family of secreted growth factors, and signal through the transmembrane serine-threonine kinase 
receptors Alk4 or Alk7. Phosphorylation by Alk4/7 results in activation of the cytosolic proteins 
Smad2/3 which, together with Smad4, lead to stimulation of endodermal genes such as Foxh1 or 
Mixl1. As a result, loss of function components of the Nodal signaling pathway result in 
compromised endoderm formation (Dunn et al., 2004; Liu et al., 2004; Shen, 2007). Consistent 
with these studies, inactivation of the Nodal antagonist Lefty2 results in excessive endoderm 
formation (Meno et al., 1999). Early studies investigating signals required for Nodal expression 
revealed that mouse embryos lacking Nodal or -catenin do not form primitive streak, suggesting 
an involvement of the canonical Wnt pathway in endoderm induction (Huelsken et al., 2000). 
Subsequent studies revealed that Wnt signaling is required to maintain Nodal expression and 





Nodal signaling induces the endodermal lineage through the expression of a network of 
transcription factors, including Sox17, Eomes, Gata4/6 and the Mix-like homeobox genes(Zorn 
and Wells, 2007). Collectively, these genes result in a commitment to an endodermal fate while 
separating endoderm and mesoderm lineages. Global expression profiling of endoderm precursor 
cells suggested that these genes are wired within multiple complex feedback loops, influencing 
each other’s expression and harboring distinct and overlapping target genes (Brown et al., 2008; 



























Figure 1.12 Fate maps of Xenopus, zebrafish and mouse (Zorn and Wells, 2009) 
Fate mapping studies in (a) Xenopus, (b) zebrafish and (c) mouse have delineated the cell types 



















1.7.2 Endoderm patterning 
Following lineage commitment, the flat sheet of endodermal germ cells undergoes a series of 
morphogenetic movements, originating from the anterior and posterior ends, which converge at 
the yolk stalk to form a gut tube (Grapin-Botton and Melton, 2000). Studies in Xenopus and mice 
revealed that by the end of gastrulation, maternal Wnt/-catenin signals at the anterior domain 
induces expression of the anterior transcription factors Hhex (Zorn et al., 1999), Mixl1 (Hart et 
al., 2002) and Foxa2 (Dufort et al., 1998). These TFs are required for foregut development and 
their differential expression at the anterior domain result in the establishment of a broad anterior-
posterior domain boundary which specifies foregut development at the anterior end. This initial 
boundary is further reinforced and maintained by graded and overlapping patterning signals, 
including FGF, Wnt and BMP ligands, which are secreted from the surrounding mesodermal 
tissues (Tam et al., 2007). At the transcriptional level, FGF4 signaling induces Cdx2 expression, 
required for hindgut specification, while repressing Hhex and Foxa2 (Dessimoz et al., 2006). 
Similarly, experiments in Xenopus and zebrafish established the role of Wnt signaling in 
promoting hindgut development and blocking foregut fate (Goessling et al., 2008; McLin et al., 
2007). Conversely, Wnt signaling must be repressed in the anterior endoderm by the Wnt 
antagonist Sfrp5 to maintain a foregut identity (Fig 1.13). At this stage, each anterior-posterior 
domain has already acquired distinct developmental potentials, evidenced by observations that 
the foregut has a higher potential to form hepatic tissues compared to hindgut cells (Fukuda-
Taira, 1981), while the hindgut is incompetent to respond to posterior foregut pancreatic 
induction by retinoid acid (Kinkel et al., 2008). Cellular signals and TFs required for domain 
induction are well-established, it is unclear how this process is regulated at the transcription 




lacking. Given that transplantation-based therapies based on in vitro derivation of endoderm 
organs have great therapeutic potential, and that human congenital malformations frequently 
afflict multiple endodermal organs simultaneously, there are growing interests in unraveling the 






























Figure 1.13 Schematic illustration of endoderm patterning (Zorn and Wells, 2009)  
Towards the end of gastrulation, endoderm domains expressing distinct TFs are patterned by 


















1.7.3 Endoderm induction from embryonic stem cells 
Human embryonic stem cells (hESCs), with their unlimited potential for self-renewal and ability 
to form all human cell types, has been widely touted as a potential cure for a wide range of 
diseases, including those affecting endoderm-derived organs such as diabetes, biliary atresia and 
ulcerative colitis. Efforts focusing on differentiation of hESCs into endoderm have relied on 
lessons learnt through in vivo genetic perturbations and explants approaches using model 
vertebrate organisms (Bernardo et al., 2011; Tam and Loebel, 2007; Zorn and Wells, 2009). 
TGF signaling through Nodal/Activin could induce an endodermal cell fate from hESCs just as 
they do in mouse and Xenopus embryos (D’Amour et al., 2005; Hudson et al., 1997; Tada et al., 
2005). Strikingly, the timing of ESC-directed endoderm differentiation by Activin, as revealed 
by molecular marker expression, closely mimics that in mouse gastrulation. Furthermore, as in 
Xenopus embryos, low levels of Activin (1-10ng/ml) induced a mesoderm fate, while high (10-
100ng/ml) doses induced DE formation.  These observations suggest that a deep understanding 
of endoderm development in model organisms can help guide efficient differentiation of hESCs 
through each developmental juncture into endoderm. Based on this principle, several in vitro 
differentiation methods have been developed to varying degrees of success based on induction 
efficiencies, yielding a mixture of DE and other cell lineages (Cheng et al., 2012; D’Amour et al., 
2005; Touboul et al., 2010). These mixed induction outcomes may arise from a lack of 
understanding of the precise involvement of each signal in DE induction, leading to inefficient 
induction or suppression of alternative lineages at each developmental branchpoint. For example, 
although BMP, FGF, Wnt and VEGF have been used, in addition to TFG pathway activation, 
for DE differentiation, these signals are also involved in mesoderm formation (Cheng et al., 2012; 




subsequent generation of endoderm organs (McKnight et al., 2010), it is imperative that signals 
at each step of endoderm formation and patterning be accurately defined. Through systematic 
provision and blockage of these signals in hESCs, considerable progress have been achieved in 
endoderm specification and patterning (Loh et al., 2014). These advances have enabled in-depth 
studies of global chromatin structure, as well as gene expression and TF occupany in these 





















1.8 Aim and objectives of thesis 
As discussed above, enhancers represent the most abundant and cell-specific elements among all 
known TRE classes. These properties, coupled with recent findings that a majority of genetic 
variants associated with human complex diseases reside on enhancers (Maurano et al., 2012), 
fueled much motivation and interest in enhancer discovery and annotation. These pursuits are 
further facilitated by the recent availability of next-generation sequencing technologies and novel 
molecular assays, such as RNA-seq, ChIP-seq and DNase-seq. These assays make it possible for 
global investigations of epigenomic profiles and identification of transcriptional enhancers.    
 
In this thesis, we aim to identify transcriptional enhancers in a genome-wide and cell-type 
specific manner, and make use of these predicted enhancers to study the role of cis-regulation in 
human endoderm development and disease. To achieve this, the main objective involves 
genome-wide profiling of the transcriptome and histone modifications in human endoderm at 
various stages of development. As vertebrate endoderm formation and patterning constitutes one 
of the earliest events during human gestation, and are largely inaccessible for detailed molecular 
studies, we will use an in vitro hESC differentiation model which recapitulates marker gene 
expression characteristic of endoderm. With this, we will examine transcriptomic profiles and 
underlying chromatin states as hESCs transit through defined developmental stages, giving rise 
to endoderm and downstream regional antecedents of endodermal organs. Although much 
progress have been made in elucidating the signaling and TF network regulating endoderm 
formation, how these signals and TFs are coordinated for  endoderm specification are largely 
unknown. As enhancers function as integrated binding platforms for lineage-specifying TFs and 




in regulating endoderm development. We also aim to investigate whether the predicted 
enhancers are enriched in variants contributing to complex diseases afflicting endodermal organs. 
Lastly, we aim to set up chromatin interaction analysis assays to study the general principles 
underlying enhancer-promoter interactions, which will aid in elucidating target genes of 
enhancers harboring disease-causing risk variants.  
 
During the course of this work, two independent groups have similarly performed human 
endoderm epigenome mappings (Gifford et al., 2013; Xie et al., 2013). Unlike this study, Xie et 
al profiled promoter chromatin remodeling, revealing the role of repressive Polycomb group 
proteins in endoderm specification. Gifford et al claimed to comprehensively map promoter and 
enhancers from all three hESC-derived germ layers, including endoderm. However, the reported 
endoderm enhancers were enriched for neural (ectoderm-derived) functions (Loh et al., 2014), 
suggesting that those elements were not endoderm-specific. This study therefore represented the 
first successful effort in high-quality endoderm enhancer discovery. Using these predicted 
enhancers we sought to understand the role of distal regulatory elements in integrating extrinsic 
signals and master regulatory TFs for endoderm lineage specification. We also aimed to test 
whether these elements are enriched for causal variants of complex diseases afflicting endoderm-
derived organs. A crucial problem in enhancer research involves target gene identification, as 
enhancer function is typically quite insensitive to distance to their target loci. The final objective 
of this work is to facilitate enhancer target gene identification through the mapping of all 
promoter-associated chromatin interactions in human cells.  





CHAPTER 2 MATERIALS AND METHODS 
2.1 Cell culture 
hESCs were propagated on matrigel- (BD Biosciences) coated plates in mTeSR1 media 
(Invitrogen). mTeSR1 media was refreshed every 24 hrs, and cultures were visually inspected 
daily for spontaneous differentiation. Differentiated cell clumps were removed thorough scraping. 
During serial passaging, culture media was aspirated and cells were incubated with collagenase 
IV at 37°C for 5 min. Subsequently, cells were scraped into clumps and transferred at a split ratio 
of 1:3 onto new coated plates. PS, DE, AFG, PFG and MHG cells were differentiated from 
hESCs (Loh et al., 2014) and were contributed by Kyle Loh and Dr. Lay Teng Ang (Genome 
Institute of Singapore). Details of the differentiation protocol is described in Chapter 2.2. 
 
MCF7 and K562 cells were obtained from the American Type Culture Collection (ATCC). 
MCF7 cells were grown in DMEM/F12 media (Invitrogen) supplemented with 5% FBS 
(Invitrogen), 10 U/ml pencillin (Invitrogen), 100 g/ml streptomycin (Invitrogen) and 4 mM L-
glutamine (Invitrogen). Cells were maintained at 37°C, 5% CO2 and passaged at 80% confluency. 
During passaging, cells were detached from culture vessel using 0.25% trypsin/0.03% EDTA 
solution at 37°C for 5 min, rinsed with fresh growth media and seeded into new culture vessels at 
a split ratio of 1:5. K562 cells were grown in RPMI 1640 media (Invitrogen) supplemented with 
5% FBS (Invitrogen), 10 U/ml pencillin (Invitrogen), 100 g/ml streptomycin (Invitrogen) and 
4mM L-glutamine (Invitrogen). Cells were maintained at 37°C, 5% CO2 and passaged when 
confluent (8×105 cells/ml). During passaging, cells were centrifuged at 100 g for 5min and 




2.2 DE specification and anterioposterior patterning from hESCs 
Confluent hESC cultures were passaged as small clumps with collagenase and seeded onto 
Matrigel coated plates. After 1-2 days of recovery in mTeSR1, hESCs were washed with F12 
(Gibco) and were treated for 24 hrs with Activin A (100 ng/mL, R&D Systems), CHIR99021 
(2 µM, Stemgent), and PI-103 (50 nM, Tocris) in CDM2 to specify APS. Afterwards, cells were 
washed (F12), then treated for 48 hours with Activin A (100 ng/mL), LDN-193189/DM3189 
(250 nM, Stemgent), and FGF2 (10 ng/mL, Invitrogen) in CDM2 to generate DE by day 3. 
Media was refreshed every 24 hrs. 
 
Day 3 DE was patterned into AFG, PFG, or MHG by 4 days of continued differentiation in 
CDM2. DE was washed (F12), then differentiated as follows: AFG, A-83-01 (1 µM, Tocris) and 
DM3189 (250 nM); PFG, RA (2 µM, Sigma) and DM3189 (250 nM); MHG, BMP4 (10 ng/mL, 
R&D Systems), CHIR99021 (3 µM), and FGF2 (100 ng/mL), yielding day 7 anterioposterior 
domains. To derive specific PFG organ domains (in CDM2 + KnockOut Serum Replacement 
(KOSR, 10% v/v, Gibco)), DE was washed, treated with DM3189 (250 nM), IWP2 (4 µM, 
Stemgent), PD0325901 (500 nM, Tocris), and RA (2 µM) for 1 day, washed (F12), and then 
differentiated 3 more days for pancreatic or hepatic induction. Pancreatic differentiation: Activin 
A (10 ng/mL), DM3189 (250 nM), IWP2 (4 µM), PD0325901 (500 nM), RA (2 µM), and 
SANT1 (150 nM, Tocris). Hepatic differentiation: A-83-01 (1 µM), BMP4 (10 ng/mL), IWP2 (4 
µM), and RA (2 µM). Day 7 pancreatic progenitors were further differentiated towards endocrine 
progenitors by treatment with RA (2 µM), DM3189 (250 nM), and DAPT (10 µM, Tocris) for 2 





CDM2 media consist of the following: 50% IMDM (Gibco) and 50% F12 (Gibco), supplemented 
with 5 mg/mL polyvinyl alcohol (Sigma, A1470 or Europa Bioproducts, EQBAC62), 1% v/v 
chemically-defined lipid concentrate (Gibco, 11905-031), 450 µM monothioglycerol (Sigma, 
M6145), 0.7 µg/mL insulin (Roche, 1376497), and 15 µg/mL transferrin (Roche, 652202). 
 
2.3 RNA-seq and data analysis 
Prior to RNA extraction, cell culture media was aspirated and cells washed with PBS. Total 
RNA was extracted using an RNeasy Mini Kit (Qiagen) coupled with on-column DNase (Qiagen) 
treatment according to the manufacturer’s protocols. RNA concentration and quality was 
assessed using a Bioanalyzer (Agilent). 1g total RNA with RIN > 9.0 was used for RNA-seq 
library construction with a TruSeq RNA Library Preparation Kit (Illumina) according to the 
manufacturer’s instructions. Briefly, mRNA purified from total RNA was fragmented to a size 
range of 300 to 500 bp and reverse-transcribed. The resulting cDNA fragments were blunt-ended 
and 3’-adenylated to allow sequencing adapter ligation. Following adapter ligation, libraries 
were PCR amplified for 15 cycles. Library size and concentration were validated by on-chip 
electrophoresis (Bioanalyzer, Agilent) and qPCR (Lightcycler, Roche). High-throughput 
sequencing was performed on a Hi-Seq2000 machine (Illumina) for 1×36+7 cycles (single read, 
36 bp for insert, 7 bp for adapter barcode). Preliminary data analyses were performed using the 
Illumina sequencing analysis software CASAVA 1.8, including image analysis, base calling, 
cluster filtering, library demultiplexing and sequence alignment. Aligned reads were used as 




analysis. Gene expression levels were normalized as RPKM (reads per kilobase of exon per 
million mapped reads) to account for gene length differences, and genes with RPKM < 1 in all 
cell types were regarded as not expressed and excluded from subsequent analyses. For each gene, 
RPKM values were normalized as percentage of the highest value across all cell types to allow 
expression profile comparison among genes with widely differing expression levels. Normalized 
expression values were clustered using the HOPACH package in Bioconductor (van der Laan 
and Pollard, 2003) to identify stage-specific transcripts. Expression heatmaps were generated 
using Java Treeview (Saldanha, 2004) and Genepattern software (Broad Institute).  
 
2.4 Reverse-transcription quantitative-PCR 
Cells were harvested and total RNA extracted using an RNeasy Mini Kit (Qiagen) as described. 
1 g total RNA was reverse-transcribed into cDNA using Superscript III (Invitrogen). cDNA 
levels for specific genes were quantified by quantitative PCR using gene-specific primers 
(Appendix I) and detected on a LightCycler 480 instrument (Roche). Gene expression levels 
were normalized to the housekeeping gene PBGD for comparison between different cDNA 
samples.  
 
2.5 Chromatin Immunoprecipitation (ChIP) and sequencing 
Adherent cells were washed with PBS and cross-linked in 1% formaldehyde for 10 mins at RT. 
Cross-linking is quenched with 0.2 M glycine for 5mins, and cells were collected by scraping 
and centrifugation. Cells were further washed twice with ice-cold PBS supplemented with 




cell pellets were thawed on ice, lysed in 1% SDS lysis buffer (50 mM HEPES-KOH pH 7.5, 150 
mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 1% SDS with 1X Complete 
Protease Inhibitor) twice and sonicated for 10 cycles at high intensity (30 s on, 60 s off) using a 
Bioruptor sonicator (Diagenode). To assess sonication efficiency, a small aliquot of sonicated 
chromatin was digested with Proteinase K (1 hr, 50°C), column-purified and electrophoresed to 
ensure a fragment size of 100 – 300 bp. Prior to immunoprecipitation, sonicated chromatin was 
diluted ten times in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 
mM Tris-HCl pH 8.1, and 167 mM NaCl) to 0.1% SDS concentration. Diluted chromatin was 
centrifuged (13,200 rpm, 10 min) to remove cellular debris and pre-cleared overnight with 
Protein G Dynabeads (Invitrogen). Concurrently, for each individual ChIP, 100 L of Protein G 
Dynabeads was washed twice (PBS + 0.1% Triton X-100), complexed with ChIP-qualified 
antibody overnight at 4°C, and washed thrice to yield antibody-bead complexes. Pre-cleared 
chromatin was combined with antibody-bead complexes and incubated overnight (4°C) for 
immunoprecipitation. Antigen-antibody-bead complexes were washed twice respectively in low 
salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.0, 150 mM 
NaCl), high salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.0, 
500 mM NaCl), LiCl wash buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.25 M LiCl, 1% Nonidet 
P-40) and TE buffer. Antibodies were eluted from beads and formaldehyde cross-linking was 
reversed overnight by mild heating (65°C), and chromatin was sequentially treated with RNase 
and Proteinase K before final column purification. The final concentration of 
immunoprecipitated chromatin was quantified by a PicoGreen assay (Invitrogen). To ensure 
specificity of the ChIP protocol, enrichment of ChIP DNA was quantified by ChIP-qPCR with 




for ChIP are anti-H3K4me2 (ab32356), anti-H3K27ac (ab4729), anti-H3K4me3 (ab8580) from 
Abcam, and anti-H3K27me3 (07-449) from Millipore/Upstate.  
 
10 ng of ChIP DNA was used for sequencing library construction using a ChIP-seq DNA sample 
Prep Kit (Illumina) with modifications. Briefly, DNA was end-repaired, 3’-adenylated, ligated 
with Illumina adapters and PCR amplified (15 cycles) with Phusion High Fidelity DNA 
polymerase (Finnzymes). Amplified fragments were purified and size-selected using AMpure 
beads (Beckman Coulter). Library size was verified by on-chip electrophoresis (Agilent 
Bioanalyzer) and library concentration quantified by qPCR. High-throughput sequencing was 
performed on a Hi-Seq 2000 system (Illumina) for 1 x 36+7 cycles (single read, 36 bp of insert 
of a multiplexed library, 7 bp for adapter barcode identification). Each library was sequenced to 
a depth of at least 37 million reads.  
 
2.6 ChIP-seq data analysis 
Sequenced reads were mapped to the hg19 human reference genome using Bowtie (Langmead et 
al., 2009), allowing up to 3 bp mismatches and discarding reads mapping to more than 1 
genomic locus. Each aligned fragment was extended by 200 bp and input-normalization and peak 
calling was performed using HOMER (Heinz et al., 2010). Histone modification peaks were 
called using a 2 kb peak width, without subtraction of local surrounding background. Enrichment 
fold changes were computed against input controls and peaks were identified based on > 4-fold 
enrichment. Enhancer peaks were considered gene-distal based a minimum 2 kb distance from 
annotated TSS. Enhancer centers were defined using the “Nucleosome Free Regions” (nfr) 




in histone modification, signifying nucleosome-free regions which facilitates TF binding. Cell 
type-specific peaks were identified using k-means clustering with Cluster 3.0 software (de Hoon 
et al., 2004) based on Euclidean distance. Histone modifications on promoters were evaluated by 
calculating ChIP-seq tag counts within a 2 kb window, normalized to corresponding tag counts 
in the input dataset. Motif enrichment was performed by comparing cell-type-specific peak 
sequences with 50,000 genomic fragments with same length and GC content of the peaks. 
Enrichment of gene ontology terms was calculated using GREAT (McLean et al., 2010) using 
the “basal plus extension” association rule, with maximal extension length of 200kb. ChIP-seq 
tracks were visualized using the Integrative Genomics Viewer from the Broad Institute 
(Thorvaldsdottir et al., 2012). 
 
2.7 Gene Set Enrichment Analysis (GSEA) 
The GSEA software (Subramanian et al., 2005) was downloaded from 
http://www.broadinstitute.org/gsea. GSEA accepts as input 1. Gene expression profile obtained 
from microarray or RNA-seq and 2. A gene set obtained based on prior biological knowledge. 
The GSEA algorithm will determine whether genes in the provided gene set are randomly 
distributed throughput the supplied gene expression profile, or preferentially enriched in the top 
or bottom in terms of expression level. Here, we used as gene expression profile microarray data 
of hESCs induced towards endodermal differentiation by Activin treatment (Bernardo et al., 
2011). The gene set consisted of the genes proximal to the top 500 putative DE enhancers by 
H3k27ac enrichment levels. These two inputs were used for GSEA analysis using default 
settings. Briefly, the gene set is ranked using the Signal2Noise metric, which ranks each gene 







Where A represents the mean of the expression level of gene g of all replicates under Activin 
treatment, and B represents the mean of expression level of gene g of all replicates in untreated 
cells. Likewise, σA represents standard deviation of gene g among all replicates under Activin 
treatment, while σB represents standard deviation in untreated cells. 
 
With these two inputs, GSEA ranks the gene list by expression level, and computes an 
enrichment score (ES) which reflects the extent to which putative DE enhancer-proximal genes 
is overrepresented at the extremes (highest and lowest) of the gene list. ES is calculated through 
a running-sum statistic through the gene list, increasing when a DE enhancer-proximal gene is 
encountered in the gene list, and decreasing when not (Subramanian et al., 2005). A p value is 
then calculated using a phenotype-based permutation test method. Specifically, genes are 
randomly assigned to either “Activin-treated” or “untreated”, re-ranked and an ES calculated. 
This process is repeated for 1,000 permutations, generating a histogram of permutated, null ESs. 
P value of the observed ES is then estimated relative to this null ES distribution.  
 
2.8 Putative functional variant identification 
To look for associations between MHG enhancers and known ulcerative colitis risk 
polymorphisms, 108 ulcerative colitis risk SNP IDs, together with their respective genomic 




(http://www.genome.gov/gwastudies) (Annex III) and used as input in the FunciSNP software 
(Coetzee et al., 2012). All known variants within a window size of 500 kb from each ulcerative 
colitis risk SNP were extracted from the relevant population from the 1000 Genomes database 
and merged with MHG-specific enhancers to identify overlaps. R2 and D’ values were calculated 
for each SNP residing within an MHG enhancer.  
 
2.9 ChIA-PET library construction 
RNAPII and CTCF ChIP was performed as described above in K562 and hESC respectively. 
Antibodies used were RNAPII 8WG16 monoclonal (Covance mms-126R) and anti-CTCF 
polyclonal (Millipore 07-729). For each library, 500 ng of ChIP-enriched chromatin fragments, 
tethered to antibody-conjugated Protein G Dynal beads, were end-repaired using T4 DNA 
polymerase (Promega) and washed thrice with ChIA-PET wash buffer (10 mM Tris-HCl, 1 mM 
EDTA, 500 mM NaCl). Each sample was divided into two equal aliquots and ligated separately 
with Linkers A and B respectively using T4 DNA ligase (Fermentas). These two linkers share 
the same nucleotide sequences except for 4 nucleotides in the middle (Linker A - TAAG; Linker 
B - ATGT) which serve as a nucleotide barcode for linker identification. Following overnight 
ligation at 16°C, the two aliquots were washed, 5’-phosphorylated using DNA polynucleotide 
kinase (NEB) and eluted in elution buffer (10 mM Tris-HCl, 1 mM EDTA, 1% SDS). To 
minimise inter-ligation between different chromatin complexes, proximity ligation is carried out 
in dilute conditions (1.2 ml chromatin in 10 ml ligation reaction). ChIA-PET constructs were 
extracted from ligation products by MmeI digestion, amplified using PCR (18 cycles), and 




library amplification, purified PCR products were electrophoresed in a 6% TBE gel (Invitrogen) 
and stained with SYBR Green I for 10min. The 223 bp band, representing amplified ChIA-PET 
ligation fragments, was gel purified, and sequenced using a Hi-Seq 2000 instrument (Illumina). 
ChIA-PET data analysis was performed by Dr Li Guoliang using the ChIA-PET tool (Li et al., 
2010).  
 
2.10 Fluorescence In Situ Hybridization (FISH) 
MCF7 cells were harvested by trypsinization, transferred to 15ml falcon tubes and swelled in 
hypotonic conditions (0.75 M KCl) for 15 min at 37°C. Cells were fixed with methanol/acetic 
acid (3/1), dropped onto glass slides and aged overnight at 37°C. Following overnight 
propagation of E.Coli harbouring BAC DNA of interest, plasmid DNA was extracted 
(Nucleobond PC500 Plasmid Purification Kit, Macherey-Nagel) and labelled by nick translation 
(Nick Translation Labelling Kit, ENZO Life Sciences) in the presence of biotin-16-dUTP or 
digoxigenin-11-dUTP (Roche). In the presence of 1mg/ml of Human Cot1 and Salmon sperm 
DNA (Invitrogen), labelled BAC clones were resuspended to 5 ng/ml in hybridization buffer 
(PBS, 2×SSC, 10% dextran sulphate, 50% formamide). Prior to hybridization, MCF7 nuclei on 
slides were digested with (0.005% pepsin (Sigma), 0.01 M HCl) at 37°C for 3min followed by 
fixation with 1% formaldehyde (Merck - Calbiochem) and dehydrated through a 70%-80%-100% 
ethanol series. Labelled probes were denatured at 75°C for 5 min and hybridized to aged slides 
(described above) at 37°C overnight. Post-hybridization washes were performed twice at 45°C in 
2×SSC, 50% formamide for 7 min each followed by 2 washes in 2×SSC at 45°C for 7 min each. 
Slides were revealed with avidin-conjugated fluorescein isothiocyanate (FITC) (Vector 




labeled probes (Roche). After washing, slides were mounted with vectashield (Vector 
Laboratories) and observed under an epifluorescence microscope (ZEISS, Image.Z2) and under 
63× lens magnification. Between 300 – 800 interphase nuclei were analyzed for each probe mix. 
Probe signals were visualized and analysed using metafer4 software. A center-to-center distance 
of 1m was used as cut-off for colocalization analysis. BACs used are listed in APPENDIX II. 
 
2.11 RNAPII immunofluorescence staining combined with DNA FISH 
MCF7 cells were grown to 70% confluency in hybridization chambers and fixed with 4% 
paraformaldehyde (PFA) (Sigma-Aldrich) for 15min at room temperature (RT) followed by 
permeabilization with 0.04% Triton X (Promega) for 30min at RT. Prior to staining, cells were 
blocked with 10% normal donkey serum (Millipore) for 1 hr at RT and incubated with mouse 
RNA polymerase II 8WG16 monoclonal antibody (Covance, 1:1000) overnight at 4°C. Cells 
were incubated with Cy3-conjugated donkey anti-mouse IgG polyclonal antibody (Millipore, 
1:1000) for 1hr at RT, after which slides were mounted with ProLong Gold antifade reagent 
containing DAPI (Invitrogen). For combined RNAPII staining-DNA FISH, RNAPII-stained cells 
were post-fixed in 4% PFA for 10 min at RT after secondary antibody incubation and 
permeabilized in 0.5% Triton X for 10 min at RT. Cells are subsequently dehydrated through a 
70%-80%–100% ethanol series, rehydrated with 2×SSC and denatured in 2×SSC/50% 
formamide at 80°C for 40 min. Prior to FISH probe hybridization, cells were incubated in 2×SSC 
for 5min at 4°C and permeabilized in 2×SSC/0.5% Triton X for 5 min at 4°C. Probe preparation 
and hybridization for FISH were performed as described for DNA-FISH. Association of RNAPII 




confocal microscope with 63x optical lens and interslice distance (Z-axis) of 0.4mm. Data was 
analysed using LSM image browser and percentage overlap was determined by manual counting. 
 
2.12 Zebrafish enhancer reporter assay 
Putative enhancer elements were PCR-amplified from 100ng human genomic DNA (Promega) 
using Phusion High-Fidelity DNA polymerase master mix (Thermo Scientific) and enhancer-
specific PCR amplification primers (APPENDIX I). Amplification products were 
electrophoresed in a 1% agarose gel for size verification, and PCR conditions were optimized to 
ensure only a single PCR band per amplification reaction was observed. Successfully amplified 
enhancers were cloned into pENTR-TOPO vectors (Invitrogen) according to manufacturer’s 
instructions, and purified using a plasmid elution kit (Qiagen Miniprep kit). Positive 
transformants were screened using colony PCR with Taq DNA polymerase (NEB). pENTR-
TOPO vectors contain recombination sites derived from bacteriophage  to facilitate 
recombination with the ZED vector through the Gateway® Technology (Landy, 1989). ZED 
vector was a kind gift from Dr. José Bessa (Bessa et al., 2009). LR recombination was performed 
using Clonase enzyme mix (Clontech) and positive recombinants were identified through BglII 
restriction digestion and further verified by single-pass sequencing. Tol2 transposase mRNA was 
prepared by in vitro transcription using the mMESSAGE mMACHINE kit (Life Technologies) 






For embryo microinjection, injection needles were prepared by pulling borosilicate glass 
capillaries (O.D.: 1.0 mm, I.D.: 0.58 mm) using a micropipette puller (P-97, Sutter Instruments) 
with the following settings: Heat=560, Pull=30, Vel=90, Time=80. The injection mix was 
prepared by mixing 2.5 ul enhancer DNA (80 ng/ul), 5 ul Tol2 transposase mRNA (50 ng/ul) and 
2.5 ul phenol red solution (0.1% in PBS, Sigma). 1nl of the injection mix was injected into each 
zebrafish embryo during the 1-cell stage. For each enhancer element, a total of 100 – 120 
embryos were injected. Embryos were observed by fluorescence microscopy between 16-36 


















CHAPTER 3 TRANSCRIPTIONAL AND EPIGENOMIC PROFILING DURING 
HUMAN ENDODERM DEVELOPMENT 
3.1 Transcriptomic profiling of endoderm differentiation and patterning 
To recapitulate human endoderm formation and subsequent derivatives along the anteroposterior 
axis, an in vitro differentiation model was employed in which hESCs are progressively induced 
to differentiate into primitive streak (PS) and definitive endoderm (DE), then subsequently 
patterned into anterior foregut (AFG), posterior foregut (PFG) and mid/hindgut (MHG) 
progenitor cells. To capture the dynamics of global gene expression patterns during this process, 
levels of polyadenylated transcripts from each of these cell types were quantified by RNA-seq. 
Following total RNA extraction, mRNA purification, library construction and high-throughput 
sequencing, 74 – 95 million raw reads per library was obtained (Table 2). These reads were 
filtered and mapped using the standard Illumina analysis pipeline (described in Materials and 
Methods), generating an average of 68 million uniquely mapped reads per library for 
downstream analyses. A transcript was considered as expressed if it presented an [RPKM] > 1 in 
all six cell types. Using these criteria, a total of 16,781 transcripts were detected over the course 
of differentiation and patterning. To study cell-type specific expression, all transcripts were 
clustered based on expression levels using the HOPACH algorithm (van der Laan and Pollard, 
2003) (Fig 3.1A). Among the 2,124 cell-type specific transcripts identified, 1,784 (84%) mapped 
to coding regions, 89 (4.2%) consisted of non-coding RNAs, while a further 250 (11.8%) 
transcripts mapped to unannotated genomic regions (Fig 3.1B). The expression levels of 12 cell-
specific transcripts were further verified by qPCR, which confirmed their stage-specific 





To investigate whether these clusters are truly representative of cell-type and region-specific 
identity, expression levels of 51 key regulatory genes in endoderm development and patterning 
were presented as a heatmap (Fig 3.1D). Characteristic of an undifferentiated state, genes 
specifically expressed in hESCs include the pluripotency markers SOX2, PRDM14 and DPPA4, 
while NANOG and OCT4 expression persists up to PS stage, consistent with previous 
observation that expression of these two genes persists until streak formation (Teo et al., 2011). 
Endoderm markers, including SOX17, CXCR4 and CER1, were specifically enriched in the DE 
cluster. Likewise, transcripts for the anterior foregut markers TBX1, PAX1 and PAX9 (Green et 
al., 2011) were enriched in AFG. Consistently, PDX1, MEIS1 and MEI2 (Fujitani et al., 2006; 
von Burstin et al., 2010) exhibited PFG-specific expression, and multiple posterior HOX 
transcripts (Illig et al., 2013) were enriched in MHG. Gene Ontology analysis was performed on 
genes enriched in each stage following differentiation (Fig 3.1E) (McLean et al., 2010). The PS 
and DE-specific cluster was enriched for the Gene Ontology term “endoderm development” (p = 
6.3×10-5) and “primary germ layer formation” (p = 4.4×10-4); AFG cluster for “pattern 
specification process” (p = 1.5×10-7); PFG cluster for “liver development” (p = 5.2×10-7); MHG 
cluster for “tube development” (p = 8.2×10-6) and “urogenital system development” (p = 2.6×10-
4). These distinct gene signature classes suggest that key endoderm developmental programs are 
regulated in a stage-specific manner, and further demonstrated that the in vitro hESC-
differentiation model employed can accurately recapitulate early stages of human embryological 
development. Our global transcriptomic data represent the first comprehensive gene catalogues 
of human endoderm differentiation, and further revealed a panel of non-coding RNAs and 




understood. These data hence represent a novel and valuable resource for future investigation of 

























Table 2 Statistics of sequenced and aligned RNA-seq reads 









ES 2,473 74,549,297 94.77 54,097,899 76.57 
PS 3,152 95,345,326 94.45 70,418,857 78.2 
DE 2,990 91,244,264 93.63 68,458,887 80.13 
AFG 3,090 94,498,635 93.44 71,416,623 80.88 
PFG 3,117 95,569,242 93.18 73,263,188 82.27 
MHG 3,099 95,183,586 93.01 68,860,031 77.78 


















































Figure 3.1 RNA-seq analysis reveals cell-type specific transcripts during endoderm 
differentiation and patterning 
(A) HOPACH clustering of RNA-seq reads to identify cell-specific transcripts according to 
expression levels. (B) Proportion of transcripts sorted according to annotation and coding 
characteristics. (C) qPCR validation of expression levels of 12 cell-type specific transcripts. (D) 
Heatmap showing expression patterns of 51 key endoderm regulatory genes. (E) Gene Ontology 













3.2 Chromatin state profiling during endoderm formation 
The precise and complex spatial-temporal gene expression patterns during early embryonic 
development are controlled by TREs found throughout the genome (Maston et al., 2006). We 
hypothesized that comprehensive profiling of chromatin states during endoderm lineage 
commitment will enable identification and annotation of such regulatory elements. ChIP-seq, 
with its ability for global unbiased mapping of protein binding or localization, was selected as 
the method of choice to profile the distribution of a panel of histone modifications (H3K4me2, 
H3K4me3, H3K27ac, and H3K27me3) during defined stages of endoderm differentiation. Prior 
to ChIP-seq library construction, efficiency of the ChIP process was first evaluated to ensure 
sufficient and specific enrichment for the appropriate histone modification of interest. One key 
factor affecting this process is antibody quality, which may exhibit substantial lot-to-lot 
variability and affect data reproducibility and biological relevance (Egelhofer et al., 2011). Due 
to a lack of understanding and available chromatin data in endoderm and subsequent derivatives, 
ChIP-qPCR was performed for TSS of well-characterized genes in hESCs (Fig 3.2). These genes 
include pluripotency markers (SOX2, DPPA4, PRDM14), general transcription/translation 
factors (BTF3, EIF3B), and housekeeping genes (GAPDH, ACTB), all of which are well-
characterized and actively transcribed in hESC. In addition, chromatin states at TSS of three 
differentiation markers (WNT8B, FOXP4, NODAL), which are not expressed in hESC, were also 
assayed. We observed that the TSS of actively transcribed genes were strongly enriched with the 
activating marks H3K4me2 (112 – 372 fold), H3K4me3 (11 – 59 fold) and H3K27ac (8 – 102 
fold), while relatively depleted of repressive H3K27me3 (1.6 – 15 fold) (Fig 3.2). Conversely, 
TSS of differentiation markers were highly marked with H3K27me3 (26 – 76 fold) but not 




– 101 fold) at TSS of differentiation markers, consistent with previous observations that 
H3K4me2 marks developmentally poised genes (Orford et al., 2008). In sum, these data 
informed that the ChIP protocol and antibodies were efficient and specific in enriching for the 
appropriate histone marks and associated genomic DNA. 
 
The validated ChIP conditions were subsequently applied on ES, PS and DE cells, and ChIP-
enriched DNA from each experiment was used for sequencing library preparation. In total, 15 
ChIP-seq libraries were constructed and sequenced (Table 3), culminating in a range of 37 – 57 
million raw sequencing reads per library. Low quality reads were filtered through the standard 
Illumina pipeline, and pass-filtered reads were mapped to the human reference genome (hg19) 
using Bowtie (Langmead et al., 2009). In total, 23 to 38 million reads aligned uniquely per 

























Figure 3.2 ChIP-qPCR validation of histone modifications in ES cells 
ChIP DNA enriched with H3K4me2, H3K4me3, H3K27ac and H3K27me3 were amplified using 
TSS-specific primers. Expression levels were normalized against negative control regions (NC1 
and NC2). Fold change values and standard deviations were determined from triplicate samples. 
Green columns represent genes which are actively transcribed in hESCs; red columns represent 


















































































































































































































































3.3 Promoter chromatin signatures for key regulators of endoderm differentiation 
To investigate promoter chromatin states underlying the dynamic, stage-specific gene expression 
patterns observed during endoderm differentiation, histone modification levels were examined at 
the promoters of 51 stage-specific genes previously identified by RNA-seq. ChIP-seq tag counts 
within +/- 2 kb of these promoters were calculated and input-normalized for all 6 cell types (Fig 
3.3A). Generally, mRNA expression at each developmental stage is associated with promoter 
enrichment of H3K4me3 and H3K27ac, with depletion of H3K27me3, as illustrated at the 
PRDM14 locus (Fig 3.3B). Notably, H3K4me2 enrichment on these promoters was largely 
invariant with expression levels. Although H3K4me2 and H3K4me3 often co-localize on active 
promoters, H3K4me2 also marks developmentally poised genes (Orford et al., 2008). H3K4me2 
enrichment on promoters during early developmental stages may serve to facilitate subsequent 
reactivation of these genes in later developmental stages.  
 
Developmental genes exhibit a bivalent chromatin structure in ES cell stage (Bernstein et al., 
2006), yet it is unclear how genes activated during different developmental stages differ in their 
poising status. To investigate this, we analyzed the chromatin states of PS/DE and gut progenitor 
genes (AFG, PFG and MHG) in the ES cell stage. 80% of PS/DE genes, which were activated 
within 24 hours of differentiation, were bivalent, compared to only 25% of gut progenitor marker 
genes (Fig 3.3C). In contrast, 75% of these gut progenitor genes, which were activated only after 
4 days of differentiation, were solely marked by repressive H3K27me3. These observations 
suggest that promoter bivalency is established in a developmental-stage specific manner, and that 




permissive state for early developmental genes, while maintaining a repressive state for later 
developmental genes.  
 
Our integrative analysis of chromatin states in relation to expression patterns further revealed 
that a subset of developmental genes with similar expression patterns exhibit distinct chromatin 
profiles. For example, both CXCR4 and CER1 exhibit similar expression profiles at the DE stage, 
yet H3K4me3 persisted in gut progenitors at the CXCR4 promoter, while CER1 promoter lost 
H3K4me3 and regained repressive H3K27me3 (Fig 3.3D,E). CXCR4 encodes a chemokine 
receptor involved in diverse developmental processes from regional specification of endoderm 
and pancreas (Katsumoto and Kume, 2013), to intestinal epithelial development (Zimmerman et 
al., 2011) and neuronal development (Stumm et al., 2003). Conversely, targeted disruption of 
Cer1, a TGF- signaling inhibitor in anterior endoderm, showed that the gene is not required for 
later development (Stanley et al., 2000). Hence, the differences in chromatin states between these 
two genes may reflect their varying roles and expression in later development stages, suggesting 




































































































Figure 3.3 Histone modification signatures around promoters of lineage specific genes 
during endoderm differentiation 
(A) Heatmaps of histone modification and RNA-seq read enrichment at TSS of 51 stage-specific 




and gut progenitors with promoter enrichment of H3K4me3, H3K27me3 or both. (D-E) 


























3.4 Identification and epigenomic profiling of endoderm enhancers 
Although promoters are important in regulating transcription initiation, enhancers are the key 
drivers of cell-type specific gene expression programs (Bulger and Groudine, 2011; Heintzman 
et al., 2009). Several genome-wide studies have successfully leveraged on H3K27ac as a tissue- 
and developmental stage-specific chromatin marker for active enhancer elements (Cotney et al., 
2012; Creyghton et al., 2010). Furthermore, the dynamics of H3K27ac enrichment are associated 
with gene expression changes during the transition from pluripotency to cell specification 



















3.4.1 H3K27ac peak profiling identifies putative endoderm enhancers 
To predict active enhancer elements and study their activation dynamics during endoderm 
differentiation, mapped H3K27ac reads were used to identify enhancer peaks. In total, 8,653, 
11,510 and 13,993 H3K27ac peaks were identified in ES, PS and DE respectively. Consistent 
with the association of H3K27ac with active promoters and enhancers (Bonn et al., 2012; Ernst 
et al., 2011; Heintzman et al., 2009), we observed that for all 3 cell types, ~45% of H3K27ac+ 
elements were TSS-proximal (0 – 2kb), while the remaining were TSS-distal ( > 2kb) (Fig 3.4A). 
We considered TSS-distal, H3K27ac+ loci as putative enhancers and identified 13,367 such 
peaks, which were further subjected to k-means clustering to obtain cell-type specific peaks. 
From this analysis, 2,052, 2,155 and 4,320 H3K37ac peaks were identified in ES, PS/DE and DE 
respectively (Fig 3.4B). We hypothesized that peaks found in PS/DE and DE contain active 
enhancers which drive an endoderm transcriptional program, and merged them for subsequent 
analyses (thereafter referred to as ‘putative DE enhancers’). Compared to flanking regions, 
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Figure 3.4 Epigenomic profiling to identify DE enhancers 
(A) Number of H3K27ac elements identified in ES, PS and DE, and their proportion according 
to distance away from the nearest TSS. (B) Heatmap illustrating k-means clustering (k=7) of all 







3.4.2 Functional annotation of putative DE enhancers 
Having identified a list of putative DE enhancers, we next asked whether these elements resided 
near genes involved in endoderm development. An unsupervised gene ontology statistical 
analysis, GREAT (McLean et al., 2010), was performed to assign each peak to annotated genes, 
followed by an analysis of functional gene annotation enrichment among the assigned genes. 
Notably, gene ontology analysis associated these peaks significantly with genes involved in 
endoderm development (p=4.53×10-30), gastrulation (p=1.07×10-25), and axis specification 
(p=5.82×10-18) (Fig 3.5A). Furthermore, these genes exhibit robust in vivo expression in mouse 
endoderm according to expression patterns recorded in the Mouse Genome Database (Bult et al., 
2008). To test whether these peaks correlate positively with proximal gene expression in 
endoderm, expression levels of transcripts located within 50kb from each putative DE enhancer 
were measured and compared in each cell-type (Fig 3.5B). Importantly, genes proximal to 
putative DE enhancers exhibited significantly higher expression in DE, demonstrating a positive 
correlation between tissue-specific enhancer activation and gene expression patterns in the 
appropriate cell-type. Collectively, these data suggest that the H3K27ac+ peaks identified 
through global chromatin state profiling of in vitro differentiation cultures represent bona fide 
























Figure 3.5 Functional annotation of putative DE enhancers 
(A) Gene ontology terms associated with DE enhancers. Blue columns represents biological 
processes, while purple columns refers to Mouse Genome Informatics (MGI) data of curated 
mouse expression information. (B) Expression levels of transcripts within 50 kb of putative DE 
enhancers measured in all 6 cell-types. The p-value stated represents the least significant p-value 









3.5 Convergence of endoderm lineage-specifying TFs with TGF- signaling effectors for 
enhancer activation 
Genome-wide analyses of enhancer function revealed that in addition to core TFs, enhancers are 
also bound by DNA-binding effectors of various signaling pathways, leading to the recognition 
of enhancers as integration hubs between extrinsic cell signaling, genomic sequence and 
epigenetic information (Calo and Wysocka, 2013; Chen, 2008; Mullen et al., 2011). We sought 
to investigate whether our putative DE enhancers bind core endoderm TFs or signaling effectors, 



















3.5.1 Binding site analysis of putative DE enhancers 
We hypothesized that DNA motif enrichment at putative DE enhancers will reveal TFs and 
signaling effectors driving endoderm enhancer activation for the initiation of downstream 
transcriptional programs. Binding site analysis revealed significant enrichment of motifs for 
GATA4, NANOG, EOMES, FOXA2, and AP-1, as well as the NODAL signaling effectors 
SMAD2/3, SMAD4 and FOXH1 on putative DE enhancers (Fig 3.6A). Notably, GATA4, 
NANOG, EOMES and FOXA2 were all reported to play key regulatory roles in endoderm 
development (Rojas et al., 2010; Teo et al., 2011). The enrichment of motif sequences of the AP-
1 transcriptional complex is consistent with the role of JNK kinases in regulating endoderm 
development (Loebel et al., 2011; Xu and Davis, 2010), illustrating a novel link between the 
JNK-AP1 signal transduction pathway and the active enhancer landscape in regulating endoderm 
lineage specification. Taken together, these observations demonstrate the association of putative 
DE enhancers with multiple core TFs of the TGF- signaling pathway, as well as master 
regulatory TFs in endoderm development, supporting a function of these elements as enhancers 



















Figure 3.6 Overrepresented DNA sequence motifs enriched at putative DE enhancers 



















3.5.2 Association of putative DE enhancers with endoderm-specifying TFs 
To validate the motif analyses data and evaluate whether putative DE enhancers are broadly 
associated with lineage-specifying TFs/signaling effectors, we adopted an integrative genomics 
approach using SMAD2/3, SMAD4, FOXH1 (Kim et al., 2011), FOXA2 (Gifford et al., 2013) 
and EOMES (Teo et al., 2011) binding profiles in endoderm, as well as our DE chromatin 
modifications. We first calculated the correlation of tag counts of these factors with chromatin 
modifications in ES, PS and DE (Fig 3.7A). EOMES and FOXH1 peaks co-clustered with 
H3K27ac in PS and DE (Cluster 1), while SMAD2/3/4 and FOXA2 peaks co-clustered with 
H3K4me2 in DE (Cluster 2). Notably, both clusters are characterized by enhancer-associated 
histone modifications. These two clusters formed a super-cluster in relation to clusters 3 and 4, 
which are characterized by promoter (H3K4me3) and repressive (H3K27me3) chromatin 
modifications, indicating that endodermal TFs broadly converged onto putative DE enhancers. 
To investigate the cell-type specificity of this overlap, we compared TF ChIP-seq intensities at 
putative DE enhancers with neural crest enhancers (Rada-Iglesias et al., 2012). Notably, binding 
of all 5 TFs enriched significantly at DE enhancers over neural crest enhancers (p < 2.2 x 10-4) 
(Fig 3.7B). To further characterize the degree of association between endoderm-specifying TFs 
and putative DE enhancers, we calculated the extent of overlap between their respective binding 
peaks. Out of 6475 H3K27ac+ peaks in DE, 5342 (82.5%) overlapped with both SMAD2/3 and 
EOMES (Fig 3.7C), indicating extensive convergence between putative DE enhancers and 
endoderm TFs.  
 
The observation that multiple NODAL signaling effectors converged onto putative DE enhancers 




transcriptional output. To investigate this, gene set enrichment analysis (GSEA) (Subramanian et 
al., 2005) was performed to query putative DE enhancer-proximal genes against differentially-
expressed genes during endoderm differentiation induced by Activin treatment on hESCs 
(Bernardo et al., 2011) (Fig 3.7D). Strikingly, the top 500 putative DE enhancer-associated genes 
were significantly enriched in the gene set positively regulated by Activin (ES = 0.51, p value < 
0.001), suggesting that putative DE enhancers positively regulate the expression of endoderm 
differentiation genes induced by NODAL. Collectively, these data suggest that endoderm-
specifying TFs drive endoderm transcriptional program through binding to, and subsequent 









































Figure 3.7 TGF- signaling effectors and endoderm-specifying TFs bind at putative DE 
enhancers in vivo 
(A) Hierarchical clustering of TF ChIP-seq datasets with ES, PS and DE chromatin 
modifications. (B) ChIP-seq profiles of SMAD2/3, SMAD4, EOMES, FOXA2 and FOXH1 and 




DE, and the extent of overlap between these peaks. (D) GSEA analysis of top 500 putative DE 
enhancer proximal genes within the gene set positively regulated by Activin (Bernardo et al., 
2011). Top panel: ES generated through a running-sum statistic, as each gene in the ranked 
expression profile is considered one by one. ES is increased when a DE enhancer proximal gene 
is observed, and decreased when a DE enhancer proximal gene is not observed. Each black 
vertical line below the ES score represents a single gene in the ranked expression profile, which 
may be increased (red) or decreased (blue) by Activin treatment compared to untreated controls. 
Bottom panel: ranked gene list, consisting of 36,704 genes and their corresponding mean 


























3.5.3 Coordination between TGF- effectors and EOMES for enhancer activation 
An interestingly observation from the analyses described above was that only a small fraction of 
all EOMES binding peaks (12.9%: 5342 out of 41324) coincided with both SMAD2/3 and 
putative DE enhancers (Fig 3.7C), prompting us to question the function of the remaining peaks. 
To study this, we examined the association between EOMES and TGF- signaling effectors with 
H3K27ac enrichment in DE. Binding profiles of these TFs were examined in relation to 
H3K27ac in DE using a non-supervised clustering approach (Fig 3.8A). EOMES binding alone 
correlated with weak H3K27ac in DE (Class I), as per TGF- effectors in the absence of EOMES 
(Class II). Notably, maximal DE enhancer acetylation was observed only with co-localization of 
EOMES with all 3 NODAL effectors (Class III) (p value < 10-84, Fig 3.8B), indicating that 
endoderm-specifying effects of TFG- signaling is determined by binding of effectors to a small 
subset of EOMES binding sites. 
 
The large proportion of Class I (36704/53902, 68.1%) binding sites suggested that these 
regulatory loci may be associated with developmental programs driven by EOMES independent 
of TGF- signaling. EOMES has been reported to regulate neurogenesis (Arnold et al., 2008a; 
Hodge et al., 2012), trophoblast and mesoderm development, as well as endoderm specification 
(Arnold and Robertson, 2009; Arnold et al., 2008b; Russ et al., 2000), and is thus considered a 
master regulator of various mesodermal- and endodermal-derived cell lineages. We hypothesized 
that EOMES-bound sites which do not overlap DE enhancers may represent regulatory elements 
driving non-endodermal developmental lineages. Consistently, gene ontology analysis of Class I 
EOMES binding sites revealed that these loci were significantly associated with genes involved 




(p=1.4 × 10-10) (Fig 3.8C). The integration of TF binding datasets with developmental stage-
specific chromatin profiles allowed the genetic dissection of TF loci involved in transcriptional 
programs of different developmental lineages.  
 
In sum, our data suggest that convergence of extrinsic signaling pathways and lineage-specifying 
TFs onto multiple TF-binding enhancer loci controls the endodermal cell fate, possibly through 
regulating key endoderm lineage specifiers and/or markers, such as SOX17 and CER1 (Fig 3.8D). 
Multiple TF-bound loci have previously been reported in mouse ES cells and heart to drive 
tissue-specific gene expression (Chen et al., 2008; He et al., 2011), and our analyses have 












































Figure 3.8 Genetic dissection of endoderm TF binding sites 
(A) Clustering of endoderm TF binding sites with H3K27ac signals in DE and ES. (B) Average 
H3K27ac tag counts in DE computed based on number of endoderm TFs bound. TFs included in 




EOMES binding sites identified from the clustering analysis in (A). (D) Examples of key 

































3.6 Endoderm enhancer priming 
We next focused on examining the mechanisms facilitating enhancer activation during DE 
differentiation. TF binding (Zaret and Carroll, 2011) and chromatin structure (Calo and Wysocka, 
2013; Rada-Iglesias et al., 2011) have been proposed to pre-mark distal regulatory elements for 
rapid target gene activation. Although SMAD2/3, SMAD4 and FOXH1 extensively occupied DE 
enhancers following differentiation, they are significantly less enriched at the same loci in ES 
cells (Fig. 3.9A). Pre-marking with H3K4me1 has been observed to correlate with 
developmental enhancer poising (Calo and Wysocka, 2013; Rada-Iglesias et al., 2011), and we 
hypothesized that additional priming mechanisms may exist. To comprehensively investigate the 
relationship between chromatin structure and enhancer poising, we overlapped putative DE 
enhancers with 17 histone modifications and chromatin modifiers in human ES cells (Ernst et al., 
2011). Surprisingly, unsupervised clustering revealed that only ~30% of putative DE enhancers 
were pre-marked with H3K4me1, indicating that this histone modification alone does not 
comprehensively identify all poised developmental enhancers (Fig 3.9B). We identified 
repressive H3K9me3 (cluster 2) as a poising mark on distal regulatory elements, extending a 
previously reported function of H3K9me3 in pre-marking promoters of transcriptional targets of 
the NODAL/TGF- pathway during endoderm formation (Xi et al., 2011). In addition, we 
discovered an enhancer cluster pre-marked predominantly by H4k20me1 (cluster 6). 
Interestingly, H4k20me1 also plays a central role in regulating RNAPII promoter-proximal 
pausing (Kapoor-Vazirani and Vertino, 2014), suggesting that a common epigenetic mechanism 
may regulate both enhancer poising and RNAPII pausing for rapid transcriptional output. We 
further observed ~25% of DE enhancers pre-marked solely by H2A.Z (cluster 1). H2A.Z is a 




chromatin structure (Goldman et al., 2010; Thambirajah et al., 2006), and was recently 
demonstrated to be enriched at promoters and enhancers in hESCs during ES self-renewal and 
differentiation (Hu et al., 2013). Importantly, H2A.Z decreases nucleosome stability and 
occupancy, promoting nucleosome displacement by TFs (Jin et al., 2009). Hence, H2A.Z may 
facilitate rapid and preferential endoderm TF binding and enhancer activation. Indeed, upon ES 
differentiation, H2A.Z-marked pre-enhancers were significantly more enriched in SMAD2/3, 
SMAD4, FOXH1 and EOMES compared to unmarked, latent pre-enhancers (cluster 5) (p value 
< 10-13) (Fig 3.9C). Collectively, our analyses revealed novel and diverse combinations of 
chromatin priming modifications, including H3K9me3, H4k20me1, and H2A.Z, which 









































Figure 3.9 A diversity of DE enhancer priming states 
(A) (left) ChIP-seq profiles of endoderm-specifying TFs (SMAD2/3, SMAD4, FOXH1 and 
EOMES) in ES cells and endoderm at 6,475 active DE enhancers. EOMES is not expressed in 
ES and no binding data is available. (right) Average signals of SMAD2/3, SMAD4 and FOXH1 
centered at DE enhancers in endoderm and ES cells. (B) Heatmap illustrating ChIP-seq 




enhancers. (C) Average TF binding signals at H2AZ-primed enhancers (red) in comparison to 
latent pre-enhancers (grey). Significance of difference between these two classes were obtained 

























CHAPTER 4 ENHANCER DISCOVERY, ANNOTATION AND VALIDATION DURING 
ENDODERM PATTERNING  
4.1 Enhancer discovery and epigenome profiling during endoderm patterning  
We performed epigenome mapping of H3K4me2, H3K4me3, H3K27ac and H3K27me3 through 
ChIP-seq in AFG, PFG and MHG progenitor cells. A total of 15 libraries were successfully 
sequenced and mapped, generating 25 to 35 million reads per library (Table 4). We identified a 
total of 16,158 gene-distal H3K27ac+ peaks from all three cell types and performed k-means 
clustering to identify cell-specific peaks, resulting in 4,071, 5,163 and 2,620 peaks representing 
putative enhancers in AFG, PFG and MHG respectively (Fig 4.1A). Consistent with an active 
enhancer signature, these H3K27ac+ elements were also strongly enriched in H3K4me2, while 
relatively depleted in H3K4me3 and H3K27me3 (Fig 4.1B). Notably, the average H3K27ac and 
H3K4me2 signals at these peaks exhibited a characteristic nucleosomal displacement “dip” 
suggestive of trans-factor binding. Furthermore, these peaks resided on genomic loci which were 
generally evolutionarily constrained, exhibiting a higher conservation score than flanking 


















































































































































































































































Figure 4.1 Identification of cell-specific H3K27ac+ peaks following endoderm patterning 
(A) Heatmap of H3K27ac profiles grouped into cell-specific classes using k-means clustering. (B) 
Average signals of H3K4me2, H3K4me3, H3K27ac and H3K27me3 at AFG, PFG and MHG 
enhancers identified through clustering. (C) Sequence conservation (phastCons score) of AFG, 














4.2 Functional annotation of enhancers 
4.2.1 Gene ontology and RNA expression analysis 
To assess whether the putative enhancers in AFG, PFG and MHG correlate with expression of 
proximal genes, transcript levels of genes within 50kb from each group of H3K27ac+ elements 
were computed from RNA-seq datasets (Fig 4.2A). Notably, these elements correlated 
significantly with increased proximal transcript levels within their respective domains. 
Functional annotation using GREAT (McLean et al., 2010) revealed associations of the 
identified elements with annotated developmental genes (Fig 4.2B). Specifically, AFG elements 
were associated with genes required for foregut morphogenesis (p < 4.8×10-12); PFG elements 
with genes involved in foregut (p < 1.7×10-12) and pancreas development (p < 1.0×10-8); MHG 
elements with genes relevant to mid- (p < 7.1 ×10-14) and hindgut morphogenesis (p < 3.7×10-12). 
Importantly, these putative enhancers were also strongly associated with genes linked to 
endodermal developmental defects identified through mouse deletion studies (Bult et al., 2008) 
(Fig 4.2C), highlighting the potential of these putative enhancer catalogues as comprehensive 

























Figure 4.2 Functional annotation of putative AFG, PFG and MHG enhancers 
(A) RNA-seq expression levels of transcripts proximal to each enhancer class. P values represent 
the least significant value between all pairwise comparisons involving the putative enhancers of 
interest. P values were calculated using paired t-test. (B) Gene ontology biological processes 
associated with each enhancer class. (C) Developmental defects associated with genes in 








4.2.2 Motif analysis of cell-type-specific enhancers 
To further establish cell-type-specific activities of these putative enhancers, we performed TF 
binding site analysis (Fig 4.3A). Among the most highly overrepresented AFG motifs included 
OTX2 (p = 10-45) and SIX1 (p = 10-29). Otx2 is a homeodomain-containing TF required for 
anterior patterning and is restricted in expression to the anterior endoderm (Ang et al., 1994; Jin 
et al., 2001). Six1 is a homeobox protein required for anterior organ development, including the 
thymus, lung and inner ear (Bricaud and Collazo, 2006; El-hashash et al., 2011; Laclef et al., 
2003). Enriched PFG motifs included hepatic progenitor specifiers HNF1B (p = 10-90), GATA6 
(p = 10-66) and FOXA2 (p = 10-16), and pancreas differentiation factor PDX1 (p = 10- 50). 
Importantly, all these TFs play significant roles in organ-specification, specifically liver and 
pancreas, from the posterior foregut endoderm (Lee et al., 2005; Lokmane et al., 2008; Zhao et 
al., 2005) (Ahlgren et al., 1996). MHG enhancers were enriched in motifs for CDX2 (p = 10- 118), 
a master regulator of intestinal specification expressed in hindgut endoderm (Gao et al., 2009), as 
well as the WNT signaling effector TCF4 (p = 10-47), required for proper hindgut formation and 
subsequent intestine development and homeostasis (van Es et al., 2012; Gregorieff et al., 2004; 
Verzi et al., 2010). To check whether the motif enrichment was specific for each type of 
progenitor cell, we sampled two motifs from each cell-type and calculated their motif densities. 
All motifs exhibited a sharp density peak corresponding to the cell-type they were enriched in 
(Fig 4.3B). In sum, TF binding site analyses corroborated foregut, midgut and hindgut 
progenitor-specific activities of the identified elements suggested by RNA-seq and Gene 



















Figure 4.3 TF binding site analysis on putative enhancers in AFG, PFG and MHG 
(A) TF motifs and their enrichment scores for each enhancer class. (B) Two TFs were selected 
from each enhancer class (AFG: OTX2 and SIX1; PFG: HNF1B and HOXA2; MHG: CDX2 and 













4.3 In vivo validation using a transgenic zebrafish model 
To validate the spatiotemporal activities of the predicted enhancers, we utilized a Tol2 zebrafish 
reporter assay system (Kawakami, 2007). This system has been demonstrated to exhibit 
reproducible germline transmission from G0 embryos to G1, with minimal G0 mosaicism (Fisher 
et al., 2006). Since then, G0 embryos have been successfully utilized for validation of human 
heart enhancers (Narlikar et al., 2010) and enhancers from mouse embryonic stem cells (Zhang 
et al., 2013b). We therefore set up a reporter vector system (Fig 4.4A) using the Tol2 ZED vector 
(Bessa et al., 2009) and analyzed reporter gene expression in G0 zebrafish embryos. Three 
elements exhibiting cell-type-specific H3K27ac enrichment were tested for their ability to drive 
expression of a GFP reporter in zebrafish embryos. All tested loci corresponded to previously-
uncharacterized genomic regions, and were proximal to TBX1, HNF1B, and CDX2 respectively. 
The TBX1-proximal AFG element drove GFP expression in zebrafish embryos (Fig 4.4B). GFP 
expression broadly corresponded with anterior tbx1 expression revealed by in situ hybridization 
(Hong et al., 2008; Kochilas et al., 2003), suggesting that the tested element is a tbx1 enhancer in 
anterior foregut progenitor cells. The PFG enhancer ~35 kb downstream of HNF1B drove GFP 
expression in zebrafish embryos which broadly corresponded to insulin-GFP signals (Fig 4.4C) 
(Song et al., 2007), suggesting H3K27ac enrichment predicted an enhancer driving HNF1B 
expression. This observation supports the hypothesis that the element is an enhancer in posterior 
foregut progenitors and is consistent with the role of HNF1B in pancreas beta cell development 
(De Vas et al., 2015). Finally, we tested a H3K27ac-enriched element within an intron of 
WNT5B in MHG, and observed GFP expression in zebrafish embryos which broadly overlapped 




suggest that the tested element is an enhancer driving WNT5B expression, consistent with the 































































































































Figure 4.4 In vivo enhancer validation in zebrafish embryos 
(A) Schematic representation of the in vivo enhancer validation process. Putative enhancers were 
PCR amplified from genomic DNA, TOPO-cloned into a transfer vector and transferred into the 
ZED reporter vector (Bessa et al., 2009) through recombination. Each enhancer-ZED vector was 
injected into ~100 zebrafish embryos during 1-cell stage. (B) AFG enhancer activity upstream of 
TBX1, compared to tbx1 in situ hybridization data. Right, top: (Hong et al., 2008); Right, bottom: 
(Kochilas et al., 2003). (C) PFG enhancer activities downstream of HNF1B, compared with 
insulin-GFP fluorescence (Right, bottom) (Song et al., 2007). (D) Intragenic enhancer at WNT5B 
locus, compared to wnt5b in situ hybridization data. Right, top: (Kudoh et al., 2001); Right, 




















4.4 Identification of a putative causative variant for ulcerative colitis 
GWAS studies have been conducted for diverse human traits and diseases over the past few 
years, and have successfully identified thousands of associated genetic variants. A major 
limitation for GWAS studies is the difficulty in interpreting the biological relevance of the 
susceptibility loci, as genotyped SNPs are designed to tag genome linkage structure and not 
disease risk. Identification of the causal variant(s) from associated SNPs is often not 
straightforward, as many risk loci fall in non-coding regions far from known genes, where 
annotation information remains limited (Maurano et al., 2012). Furthermore, many risk SNPs 
exist in strong linkage disequilibrium with other variants in proximity, further expanding the 
search space for the causal variant. Large-scale open chromatin mapping in multiple human cells 
and tissues revealed enrichment of risk variants at DNaseI-hypersensitive sites, implicating TREs 
in common human disease risk (Maurano et al., 2012). Our GREAT analysis of endoderm 
domain-specific enhancers revealed associations of these elements to various developmental 
disorders (Fig 4.2C), prompting us to question whether these enhancers may harbor causal 
variants of human complex diseases involving endoderm organs, such as the intestines.  
 
Ulcerative colitis is a complex disease characterized by inflammation and ulceration of the large 
intestine epithelium lining. The exact cause of this disorder is unknown, but likely involves 
multiple contributing factors including genetics, stress and diet. More than 100 risk loci have 
been reported to be associated with the disease (Anderson et al., 2011; Jostins et al., 2012), yet 
how these loci affect disease phenotype is largely unknown. Although treated as an autoimmune 
disorder, multiple studies have highlighted intestinal epithelial dysfunction as a contributing 




2009; Salim and Söderholm, 2011; Shen et al., 2009). Because MHG enhancers were associated 
with genes regulating hindgut morphogenesis and proper intestine and colon development (Fig 
4.2B), we set out to test whether these enhancers may include causal variants contributing to 
ulcerative colitis.  
 
To investigate this we obtained a list of 108 published ulcerative colitis-associated SNPs 
(tagSNP) from the NHGRI GWAS catalogue (www.genome.gov/gwastudies) and overlapped all 
known SNP variants from the 1000 Genomes Project within 250kb from each tagSNP with 2,620 
MHG enhancers. A total of 2,618 SNPs overlapped MHG enhancers, of which 1,073 were linked 
to a tagSNP (r2 > 0) (Fig 4.5A). We refer to these linked SNPs as “putative causal SNPs” and 
sorted them according to linkage strength and distance from tagSNPs. Out of all 108 tagSNPs, 36 
were in linkage with at least one putative causal SNP (r2>0). A further 8 out of these 36 tagSNPs 
were in relatively strong linkage (r2 > 0.3) with at least one putative causal SNP (Fig 4.5B) 
(Table 5). Strikingly, tagSNP rs17085007 was linked to 12 putative causal SNPs, of which 3 
were in absolute linkage (R2 = 1.0) (Table 5). rs17085007 has been identified as a UC risk locus 
in Japanese (Asano et al., 2009), European (Jostins et al., 2012) and Korean (Yang et al., 2013) 
populations. It resides on chr13q12.13, a non-coding region approximately 110kb downstream of 
USP12. Like most non-coding risk variants, the biological significance of disease association 
underlying this SNP is unknown. Fine mapping revealed a 74kb linkage block surrounding 
rs17085007 (Asano et al., 2009), which overlapped an MHG enhancer cluster (Fig 4.5C). ChIP-
seq data from an additional panel of ENCODE cell types failed to reveal any histone 




high sequence conservation (Fig 4.5D). Disruption of an/multiple MHG enhancer(s) may 


















































































































Figure 4.5 Ulcerative colitis causal variant identification using MHG enhancers 
(A) Distribution of 1000 Genomes SNPs (1kgSNPs) by R2 values to ulcerative colitis tagSNPs. 
(B) Correlated risk SNPS which overlapped MHG enhancers, refered to as putative causal 
variants. These SNPs are sorted according to strength of linkage and distance from tagSNPs, and 
red dots represent putative causal SNPs in relatively strong linkage (R2 >0.3) with tagSNPs. (C) 
Fine mapping of a 290kb region around the ulcerative colitis-associated SNP rs17085007, 




enhancer elements. (D) Histone modification profiles of MHG cells and five ENCODE cell types 










































4.5 Risk locus target gene identification 
Local chromosome structure organized by CTCF binding has been recently shown to be 
important for the expression super-enhancer driven genes (Dowen et al., 2014). To investigate 
chromatin organization at 13q12.13, we made use of CTCF chromatin interactions detected by 
ChIA-PET in hESC and MCF7 cells (unpublished data from Ruan Lab). CTCF binding is 
associated with looping interactions to both active and inactive promoters, and has been 
proposed as a global organizer of long range chromatin interactions (Jin et al., 2013; Phillips and 
Corces, 2009). Given that CTCF binding is largely invariant between different cell types (Kim et 
al., 2007), we reasoned that CTCF-associated chromatin interactions can provide general insights 
into higher-order chromatin organization across multiple cell-types. Extensive CTCF-associated 
chromatin loops were observed extending over 1 Mb, linking the rs17085007 locus to CDX2 (Fig 
4.6A) in both hESC and MCF7 cells. In parallel, we examined Hi-C chromatin interactions in 
IMR90 fibroblast cells (Jin et al., 2013) and observed similar looping interactions with the CDX2 
locus (Fig 4.6B), suggesting that chromatin topology at this locus is broadly similar between 
different cell types. We validated this interaction using DNA FISH in the colon cell line HCT116 
and observed significant colocalization of the two loci for both alleles (Fig 4.6C). CDX2 is 
crucial for intestine specification from hindgut endoderm (Gao et al., 2009; Grainger et al., 2010) 
and is important for maintaining the balance of epithelium proliferation-differentiation (Lorentz 
et al., 1997; Suh and Traber, 1996). Importantly, CDX2 expression was markedly reduced in 
ulcerative colitis patients (Coskun et al., 2012). These data suggest that CDX2 is the target gene 










































Figure 4.6 Target gene identification for risk locus 13q12.13 
(A) H3K27ac signals at 13q12.13 in endoderm derivatives, and long range interactions with 
CDX2 revealed through CTCF ChIA-PET. (B) Genome topology of the same locus based on Hi-
C data. (C) DNA-FISH validation of interaction between 13q12.13 risk locus (test/positive) and 
CDX2 locus (bait) in HCT116 colon cell line. A control probe (negative) was selected 
equidistant from CDX2 as the test probe. n refers to the number of nuclei counted; 1x and 6.6x 
refers to the control-normalized fold changes in interacting nuclei count in the control and test 




















CHAPTER 5 ANALYSIS OF GLOBAL CHROMATIN INTERACTIONS IN 
TRANSCRIPTION CONTROL 
5.1 RNAPII ChIA-PET library construction in K562 cells 
In this study, we hypothesized that application of ChIA-PET to components of the general 
transcription machinery, such as RNAPII, allows investigation of global transcription-associated 
interactions between enhancers and promoters. To this end, we have constructed ChIA-PET 
libraries for RNAPII in the myelogenous leukemia cell line K562 (Zhang et al., 2012a), as part 
of a more comprehensive study involving five human cell lines (Li et al., 2012). Formaldehyde 
cross-linked chromatin was sonicated for RNAPII ChIP to a size range of 200 – 500 bp (Fig 
5.1A), and 100 ng of ChIP DNA was used as input for ChIA-PET library construction. The 
8WG16 RNAPII antibody, which recognizes the initiation form of RNAPII, was used for all 
ChIP experiments. This antibody binds the unphosphorylated consensus repeat, YSPTSPS, and 
allows for enrichment of both pre-initiatiation and initiating forms of RNAPII (Phatnani and 
Greenleaf, 2006). Hence, the 8WG16 epitope specifically enriches for promoter-bound RNAPII 
much more efficiently than RNAPII on coding regions or 3’ ends (O’Brien et al., 1994). This 
allows the ChIP protocol to enrich for total promoter-associated RNAPII, which will ensure a 
comprehensive overview of all RNAPII- and promoter-associated chromatin interactions. 
Subsequent to proximity ligation and PET purification, PCR was performed for library 
amplification and resolved by gel electrophoresis, yielding an approximately 230 bp product (Fig 
5.1B). Amplified libraries were resolved using on-chip electrophoresis to validate fragment size 















Figure 5.1 RNAPII ChIA-PET library construction (Zhang et al., 2012a) 
A) Gel electrophoresis of formaldehyde-fixed, sonicated chromatin DNA from K562 cells. B) 
Purified ChIA-PETs were amplified using 18 and 20 PCR cycles. Amplified PETs appear as a 
sharp, distinct 223 bp band. The 40 bp bands represent excess unligated adapters. C) Bioanalyzer 







5.2 Distinct models of RNAPII-associated chromatin interactions 
K562 RNAPII ChIA-PET libraries were constructed and sequenced in replicates, generating 
about 14 million tags per library. Sequenced tags were mapped to the human genome for binding 
peak and interaction cluster calling by Dr Li Guoliang using the ChIA-PET tool (Li et al., 2010) 
(Table 6). Close to 27,000 RNAPII peaks and 65,000 interaction clusters were identified per 
library. Among the identified interactions, more than 34,000 interactions were observed in both 
libraries, representing approximately 53% of interactions identified in each library (Fig 5.2). We 
subsequently pooled all interactions from both libraries for subsequent analyses. Among the 
genome-wide RNAPII interactions identified, 16,597 (17.3%) represented promoter-promoter 
(P-P) interactions, while 27,438 (28.6%) and 39,046 (40.7%) were promoter-enhancer (P-E) and 
enhancer-enhancer (E-E) interactions respectively. The large number of P-P and E-E interactions 
suggests that a significant number of genetic loci may be coordinately transcribed. Such P-P and 
E-E interactions were also widely observed in MCF7 cells (Table 6). Based on the connectivity 
between pairs of interactions, these interactions could be combined to form complex interactions, 
from which three distinct interaction types were identified (Fig 5.3A). “Basal” promoters (BP) 
are characterized by isolated RNAPII binding; “single-gene” interactions (SG) include a single 
promoter interacting with one/multiple enhancers; “multi-gene” interactions (MG) consist of 
multiple interacting promoters and enhancers. A total of 6,223 interaction models were identified. 
Although there were only 1,328 (21%) MG interaction clusters, these clusters contained 11,723 
genes, constituting 61% of all genes involved in the interaction models (Fig 5.3B). These data 
suggest that in addition to the classical ‘enhancer-promoter’ transcription model, promoters and 































Table 6 Statistics of sequenced tag counts, RNAPII peaks, interaction clusters and 
interaction types in K562 cells%  





















(13.4%) K562-2 14,365,592 27,046 65,961 







(16.9%)) MCF-2^ 15,622,720 27,683 24,126 
#
 Interaction clusters with PET counts greater than 3 
* Interaction type computed using total number of interaction clusters from both replicates  
^
 MCF7 interaction data were generated by other members of the lab 
%


























Figure 5.3 Three models for RNAPII-associated chromatin interactions (Li et al., 2012) 
A) Basal – RNAPII peak at promoter. Single-gene – single enhancer to promoter. Multigene – 
several enhancers and promoters converging. B) Proportion of single-gene, basal-promoter and 










5.3 Validation of chromatin interactions 
To validate the RNAPII-associated interactions identified by ChIA-PET, DNA FISH analysis 
was performed on three randomly-selected intrachromosomal interactions. At each test site, a 
control probe was selected equidistant from the predicted interacting probe pair, and probe 
interactions were counted in at least 300 nuclei for each interaction. All test-probe pairs showed 
significantly higher levels of co-localization than the control probe (Fig 5.4A). In addition, 5 
randomly selected interchromosomal interactions were similarly validated (Fig 5.4B). Compared 
to the control probe (-), test probes (+) targeting different chromosomes showed significantly 
higher co-localization levels. These data indicate that most chromatin interactions captured by 
RNAPII ChIA-PET were genuine. 
 
The multi-gene interactions identified suggest that interacting genes may be coordinately 
transcribed in a postulated “transcription factory” (Cook, 1999). To study the link between multi-
gene interacting loci and transcription factories, I performed 3D-DNA fish combined with 
RNAPII IF staining of MCF7 nuclei for 4 multi-gene interacting loci. All 4 tested multi-gene 
interaction loci (green) showed significant association with RNAPII IF staining (red) (Fig 5.4C). 
These data demonstrated a convergence of multi-gene interacting loci with regions of active 
RNAPII transcription, supporting the hypothesis that chromatin interactions provide a structural 






















Figure 5.4 Validation of RNAPII-associated chromatin interactions 
A) DNA-FISH validation for three single-gene interactions in MCF7. Negative denotes a control 
BAC probe approximately equidistant from the bait (green), while positive denotes a test BA 
probe. n denotes the total number of nuclei analyzed. Control-normalized fold changes in 
interacting nuclei count in the control and test experiments were denoted by “x” at the bottom 
right corner. P values were calculated using the Fisher’s Exact Test. B) DNA FISH validation of 
five randomly chosen interchromosomal interactions. “+” denotes positive test probe pairs, while 
“-” denotes non-interacting control probe pairs. C) Colocalization analysis of multi-gene loci 
with RNAPII foci. RNAPII-IF staining (red) with four multi-gene loci (green, MED20, PLEC1, 
SYVN1, HIST1). Overlaps between RNAPII foci, multi-gene loci and control locus were 



















5.4 Enhancer-promoter interactions and disease-associated loci 
The identification of thousands of enhancer-promoter interactions using model cell lines in this 
study suggests that the target genes of non-coding disease-causing mutations or regulatory 
variants may be revealed. Consistent with this hypothesis, RNAPII ChIA-PET in MCF cells 
revealed abundant interactions at the SHH locus with an enhancer ~1Mb upstream (Fig 5.5A). 
Importantly, mutations within this enhancer has been reported to cause the congenital disorder 
preaxial polydactylyl through disruption of SHH transcription (Lettice et al., 2002).  
 
In another example, we examined the IRS1 locus, which was demonstrated to harbor a type II 
diabetes (T2D) susceptibility locus (Kilpeläinen et al., 2011; Rung et al., 2009). The disease 
locus resides in a gene desert ~600Mb downstream of the IRS1 promoter, yet no direct molecular 
link has been demonstrated between these two genetic loci. Here, we identified chromatin 
interactions between the IRS1 promoter and two downstream enhancers ~600 kb and 1 Mb away. 
Importantly, the more proximal enhancer coincides with the reported T2D risk locus (Fig 5.5B), 
suggesting that genetic variants at this locus may impair enhancer function and disrupt IRS1 
expression, leading to increased disease risk. We further validated the 1 Mb chromatin 
interaction with IRS1 using DNA-FISH (Fig 5.5B) and showed that interactions identified within 
this region are genuine. Hence, chromatin interaction data may reveal the genetic targets of 

























Figure 5.5 Identification and validation of enhancer-promoter interactions involved in 
disease  
A) Interaction between the SHH gene and its upstream enhancer located approximately 1Mb 




insulin resistance susceptibility locus. The 1.1Mb interaction was validated by DNA-FISH. 
Screenshots of genetic loci and chromatin interactions were adopted from (Li et al., 2012). 
Control-normalized fold changes in interacting nuclei count in the control and test experiments 

























CHAPTER 6 CONCLUDING REMARKS 
6.1 Endoderm enhancer discovery 
The precise, yet variable and complex gene expression patterns characteristic of development are 
largely mediated by enhancers, which function as an integrating platform mediating crosstalk 
between extracellular signals and encoded genetic information. The development of ChIP and 
high-throughput sequencing has made possible the unbiased identification of thousands of 
enhancers in multiple cell and tissue types (Bernstein et al., 2012; Visel et al., 2009b). In this 
study we have coupled an in vitro endoderm differentiation model with high-throughput 
sequencing for transcriptome and epigenome mapping, allowing comprehensive enhancer 
prediction and discovery in these developmentally transient cell states. Despite the physiological 
importance of endoderm-derived organs, including the lung, liver, pancreas and intestines, our 
understanding of the regulatory mechanisms driving endoderm differentiation remains 
rudimentary. Enhancer discovery through epigenome profiling may not only contribute to a 
better understanding of genome-environment crosstalk underlying distinct cellular states and 
behavior, but also have the potential to aid in annotation of genetic determinants underlying 
disease predisposition, as illustrated in this study. 
 
Efforts to identify transcriptional enhancers in a high-throughput manner have focused on the 
trans-acting factor EP300 (ref), as well as the chromatin marks H3K4me1 H3K4me2 and 
H3K27ac. Among these modifications, H3K27ac has been identified to be strongly enriched with 
active promoters and enhancers in tissue culture models (Creyghton et al., 2010; Hawkins et al., 
2011; Rada-Iglesias et al., 2011). Subsequent studies successfully used H3K27ac to identify 




limb specification in mouse, rhesus macaque and human (Cotney et al., 2013). Cell-type-specific 
enhancers can be further detected through cross-comparisons of H3K27ac in multiple cell types 
for increased specificity (Cotney et al., 2012). In this study, we focused on H3K27ac as cells 
transit from hESC to endoderm derivatives to obtain a comprehensive catalogue of putative 
enhancers driving dynamic and developmental-stage-specific transcriptional programs during 
endoderm formation. Our stringent criteria for defining putative enhancers resulted in a 
catalogue of strongly enriched (> 4 fold tag count over input), gene-distal H3K27ac+ elements, 
which are also enriched in H3K4me2 while depleted in H3K4me3 and H3K27me3 (Fig 4.1B). 
We note that H3K27ac alone is insufficient for conclusive enhancer discovery (Cotney et al., 
2012), and that supplementation of our current datasets with endoderm-specifying TF binding 
profiles, such as SOX17, CXCR4 and MIXL1, will allow for more comprehensive and accurate 
enhancer identification. The feasibility of such approaches is illustrated by a recent study 
examining the binding dynamics of 38 TFs in relation to epigenome and transcriptome changes 
during hESC differentiation (Tsankov et al., 2015). Such enhancer catalogues not only serve as a 
valuable resource for understanding embryonic transcription regulation, but may also facilitate 
the discovery of regulatory variants underlying common diseases afflicting endoderm-derived 
organs, as illustrated here for rs17085007 associated with ulcerative colitis risk. The approach 
used in this study should be broadly applicable to other in vitro cell differentiation models, such 
as cardiomyocytes (Lian et al., 2013) and renal progenitors (Takasato et al., 2014), and is 
expected to reveal further insights in development and disease relevant to these cell lineages.   
 
Our analysis of DE enhancers revealed that sequence information encoded in DE enhancers are 




effectors SMAD2/3, SMAD4 and FOXH1. In addition to endoderm (Teo et al., 2011), EOMES 
is also required for specification of cardiac mesoderm (Costello et al., 2011), and it is unclear 
how a single TF can specify progenitor cell fates in these two non-overlapping germ layers. Our 
integrative analysis of the binding profiles of these TFs in DE, coupled with H3K27ac as readout 
of functional binding, revealed a unique set of co-bound regulatory elements associated with an 
endoderm transcriptional program. Cell-fate decisions within the primitive streak have been 
suggested to be regulated by graded levels of NODAL signaling; a high level of Nodal/Smad2/3 
signaling is required for DE specification, while low levels of Nodal are sufficient to induce 
mesoderm formation (Costello et al., 2011; Dunn et al., 2004; Vincent et al., 2003). Epigenome 
profiling in DE revealed that strong H3K27ac enrichment is associated with high SMAD2/3/4 
occupancy, whereas elements bound by EOMES with weak SMAD2/3/4 are associated with 
mesoderm and cardiac development (Fig 3.8). Hence, a subset of DNA-bound EOMES 
cooperates with NODAL signaling to induce endoderm differentiation, whereas at other loci 
EOMES may associate with other DNA binding partners for mesoderm specification through a 
SMAD2/3- and FOXH1-independent mechanism. It will be interesting to examine the 
relationship between NODAL effectors, EOMES and other regulatory TFs predicted to be 
enriched on DE enhancers, e.g. GATA4 and NANOG (Fig 3.6). This work further identified an 
overrepresentation of AP-1 motifs on DE enhancers, suggesting that transcriptional effectors of 
the JNK signaling pathway assemble on DE enhancers. Impaired JNK activity in mouse ES cells 
and embryoid bodies led to reduced expression of endoderm lineage markers such as Sox17 and 
Hnf1 (Loebel et al., 2011; Xu and Davis, 2010). This is consistent with the current finding that 
JNK signaling effectors assemble on DE enhancers and highlight the potential of JNK pathway 




observations suggest that chromatin signatures in the relevant cell types can reveal the role of 
specific signaling pathways in developmental gene expression.  
 
Enhancer discovery through chromatin profiling is complement by other next-generation 
sequencing approaches, such as DNase-seq and TF ChIP-seq. Collectively, these assays have 
greatly expanded our knowledge of enhancer localizations, properties and functions (Bulger and 
Groudine, 2010; Shlyueva et al., 2014), which in turn have spurred other novel methods for 
enhancer discovery. For example, publicly available enhancer catalogues have facilitated 
computational dissection of enhancer sequence features and highlighted the potential of in silico 
approaches for accurate enhancer prediction (Yáñez-Cuna et al., 2014). Sequencing of enhancer-
associated bidirectional capped RNAs has been reported as a more sensitive and reliable 
predictor of enhancer activity (Andersson et al., 2014). Despite the high-throughput nature of 
these approaches, the predicted elements require additional validation assays as readout for 
enhancer function, which are laborious and low-throughput in nature. To overcome this 
limitation, several innovative assays were recently developed, combining enhancer discovery and 
validation into a single high-throughput experiment. These methods include STARR-seq (Arnold 
et al., 2013), SIF-seq (Dickel et al., 2014) and FIREWAch (Murtha et al., 2014). The application 
of these novel enhancer discovery techniques, together with targeted genome-editing techniques 
using site-specific nucleases (Gaj et al., 2013) are foreseen to translate genomic information into 








6.2 ChIA-PET analysis of global chromatin interactions 
 
Through ChIA-PET analyses of RNAPII, we have comprehensively mapped transcription-
associated chromatin interactions between promoters and distal regulatory elements. Not only do 
promoters contact their respective enhancers, we also observed extensive enhancer-enhancer and 
promoter-promoter interactions, suggesting extensive looping of RNAPII binding sites into 
higher-order interaction complexes. The clustering of a large number of genes into higher-order 
structures may provide the structural basis for coordinated transcription regulation of different 
genes, consistent with the hypothesis that highly active transcriptional units gather at certain 
concentrated foci of RNAPII and offers mechanistic insight into transcription factories. This idea 
is further confirmed through DNA-FISH coupled with immunostaining, where we demonstrated 
the physical association of these interaction complexes with RNAPII foci. The clustering of 
multiple genes into transcription units may offer a structural explanation to the recent 
phenomena of pervasive transcription in intergenic regions (Jensen et al., 2013). In addition, this 
model is in principle akin to the bacterial operon as a mechanism for coordinated transcription 
regulation of related genes, further advancing the notion that similar biological concepts apply in 
eukaryotic and bacterial systems despite differences in complexity and structure. We note that 
the RNAPII interactions observed in this study are associated with pre-initiation forms of the 
protein, and not all interactions captured represents active transcription or elongation events. The 
interactions identified can be complemented with transcriptomic and epigenetic data to allow 
dissection of different transcriptional states. Alternatively, ChIA-PET can be performed on other 
phosphorylated formed of RNAPII, such as Ser5P (initiating form) or Ser2,5P (elongating form) 




coverage, will allow even more comprehensive analysis of transcription-associated chromatin 
interactions and potentially reveal more diverse types of regulatory interaction classes. 
 
Current 3C-based methods investigating genome organization relies on capturing crosslinked and 
ligated chromatin from a large population of cells for contact frequency quantification. The result 
is an averaged set of chromatin interactions which is assumed to represent the dominant 
conformation within the entire cell population. However, population-averaged assays disregard 
the presence of biologically relevant subpopulations and may poorly reflect the actual state in 
either the majority or any subpopulation of cells (Altschuler and Wu, 2010). To address this 
issue, Kalhor et al. developed a computational strategy which employed a scoring function to 
define the genome as a set of models each representing a spatial variant in different cells (Kalhor 
et al., 2011). By iteratively deriving each model from primary input data, cell-to-cell variants are 
independently and reproducibly reflected. The combination of this strategy with existing 
genome-wide methods, such as Hi-C and ChIA-PET, may overcome the limitations of chromatin 
interaction averaging.  
 
Experimentally, the requirement for large cell numbers for current high-throughput chromatin 
interaction assays precludes their application to many interesting biological samples, such as 
patient DNA. This requirement may be augmented by increasing the length of current ChIA-PET 
tags from the current 20 bp by MmeI restriction digestion, to 27 bp by EcoP15I digestion. Longer 
tags map to the genome with greater accuracy, reducing the number of false positive chromatin 
interactions and improving the coverage of chromatin interactions at a given sequencing depth. A 
non-enzymatic approach for obtaining longer PETs is to sonicate the ChIA-PET ligation 




then be purified using streptavidin-magnetic beads and subjected to Illumina paired end 
sequencing analysis at 75/105 bp from both ends.  Another factor influencing cell number 
requirement involves the over-amplification of DNA templates derived from small number of 
cells, resulting in high redundancy and low interaction complexity. A potential solution involves 
the use a single molecule sequencing platform, such as the SMRT system by Pacific Biosciences, 
to overcome the requirement for library PCR amplification.  
 
All 3C-derived methods rely on formaldehyde fixation of cells to crosslink proteins and DNA 
which are in physical proximity, providing a snapshot representation of chromatin structure. As 
formaldehyde has a relatively short crosslinking arm of 2Å, it may not, in principle, efficiently 
crosslink certain proteins which are more distantly bound to DNA. For example, both the histone 
deacetylase Rpd3 [95] and MTA3 [96], a component of the Mi-2/NuRD histone deacetylase 
complex, are refractory to formaldehyde crosslinking, necessitating the use of a second 
crosslinker with a longer spacer arm. These studies suggest that additional crosslinking using 
reagents of varying spacer arms are more effective in preserving large multiprotein complexes 
and possibly their associated chromatin interactions. Indeed, ChIA-PET experiments using 
ethylene glycol bis(succinimidyl succinate) (EGS) in combination with formaldehyde increases 
chromatin interaction complexity (unpublished observations, Ruan Lab).  
  
The current improvements in sensitivities and scales at which interactions between genomic loci 
can be detected and analyzed calls for assays for functional testing of the identified interactions. 
The synthetic zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases 




produce simultaneous targeted breaks on the same chromosome at distances up to 15Mbs, 
producing large deletions at frequencies of 0.1-10% in a native chromatin environment in human 
cells (Lee et al., 2010; Urnov et al., 2010). CRISPR represents a more efficient alternative to 
ZFNs and TALENs, where target specificity of the Cas9 endonuclease is obtained through a 
guide RNA which can be designed complementary to any genomic locus (Wiedenheft et al., 
2012). The versatility of the CRISPR systems is likely to make it the method of choice for 
targeted perturbations of chromatin interactions.  
 
Genome-wide association studies (GWAS) have identified a large number of genetic loci 
associated with disease susceptibility. Most of these loci reside in noncoding regions, suggesting 
that mutations in enhancers may account for a large fraction of disease-associated risk (Visel et 
al., 2009a). While GWAS-associated loci can be overlapped with ENCODE data-defined 
genetic/epigenetic descriptors obtained through DNase-seq and ChIP-seq (Hazelett et al., 2014; 
Rhie et al., 2013), the question of how noncoding disease risk elements are connected to gene 
functions remains unresolved. Using RNAPII ChIA-PET analyses, we have comprehensively 
identified enhancers and their target genes in several human cell types. As illustrated by the SHH 
and IRS1 loci, long range interaction data can provide the connectivity of GWAS risk loci to 
their target genes and facilitate functionalization of these disease risk-associated elements. As 
transcriptional enhancers are highly cell-type-specific, we expect that the application of ChIA-
PET to disease-relevant cell types is expected to provide further mechanistic explanations for 
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APPENDIX I - OLIGONUCLEOTIDE SEQUENCES USED IN THIS STUDY 
qPCR primers for RNA-seq validation 
Reverse transcription qPCR primers Sequence 
PBGD-F (housekeeping) GGAGCCATGTCTGGTAACGG 





















CDX2-F F: GGGCTCTCTGAGAGGCAGGT 
CDX2-R CCTTTGCTCTGCGGTTCTG 
PDX1-F F: GCGTTGTTTGTGGCTGTTGCGCA 
PDX1-R AGCTTCCCCGCTGTGTGTGTTAGG 
 
qPCR primers for ChIP enrichment validation 

































ChIA-PET linker and adapter sequences 
Linkers Sequence 
Linker A GGCCGCGATATCTTATCCAAC 
Linker B GGCCGCGATATACATTCCAAC 
Adapters Sequence 
Adapter A CCATCTCATCCCTGCGTGTCCCATCTGTTCCCTCCCTGTCTCAGNN 
Adapter B CTGAGACACGCAACAGGGGATAGGCAAGGCACACAGGGGATAGG 
PCR primers Sequence 
Primer A AATGATACGGCGACCACCGAGATCTACACCCTATCCCCTGTGTGCCTTG 
Primer B CAAGCAGAAGACGGCATACGAGATCGGTCCATCTCATCCCTGCGTGTC 




PCR primers for enhancer validation in zebrafish 











APPENDIX II – BAC PROBES USED FOR DNA-FISH 
Intrachromosome (related to Fig 4.6C, Fig 5.4A and Fig 5.5B) 
Test mix Control mix 
RP11-766A9 + RP11-463D24 RP11-766A9 + RP11-979M22 
RP11-191N14 + RP11-915D14 RP11-191N14 + RP11-92F20 
RP11-80F13 + RP11-795I20 RP11-80F13 + RP11-482K16 
RP11-136G6 + RP11-780D7 RP11-136G6 + RP11-903H1 
 
Interchromosome (related to Fig 5.4B) 
Test mix Control mix 
RP11-727F15 + RP11-143M10 RP11-727F15 + RP11-563H6 
RP11-626F12 + RP11-556I13 RP11-626F12 + RP11-563H6 
RP11-727F15 + RP11-419E4 RP11-727F15 + RP11-563H6 
RP11-286L5 + RP11-107L14 RP11-286L5 + RP11-563H6 
RP11-286L5 + RP11-419E4 RP11-286L5 + RP11-563H6 
 
Immunofluorescence-DNA FISH 





















APPENDIX III – ULCERATIVE COLITIS SNPS FROM NHGRI GWAS CATALOG 
108 TagSNPs for ulcerative colitis from the NHGRI GWAS catalog 
No. Coordinates (chr:position) SNP ID Population 
1 13:27531267 rs17085007 ASN 
2  16:86009740 rs16940186 ASN 
3 1:20200990 rs4654903 ASN 
4 16:86014241 rs16940202 ASN 
5 1:2501338 rs10797432 EUR 
6 1:20171860 rs6426833 EUR 
7 1:200101920 rs2816958 EUR 
8 2:198881668 rs1016883 EUR 
9 2:199523122 rs17229285 EUR 
10 3:53062661 rs9847710 EUR 
11 4:103511114 rs3774959 EUR 
12 5:594083 rs11739663 EUR 
13 5:134443606 rs254560 EUR 
14 6:32612397 rs6927022 EUR 
15 7:2789880 rs798502 EUR 
16 7:27231762 rs4722672 EUR 
17 7:107480315 rs4380874 EUR 
18 7:128573967 rs4728142 EUR 
19 11:96023427 rs483905 EUR 
20 11:114386830 rs561722 EUR 
21 15:41563950 rs28374715 EUR 
22 16:30482494 rs11150589 EUR 
23 16:68591230 rs1728785 EUR 
24 17:70641698 rs7210086 EUR 
25 19:47123783 rs1126510 EUR 
26 20:33799280 rs6088765 EUR 
27 20:43065028 rs6017342 EUR 
28 1:67705958 rs11209026 EUR 
29 1:161479745 rs1801274 EUR 
30 1:206939904 rs3024505 EUR 
31 2:61204856 rs7608910 EUR 
32 2:241579108 rs4676406 EUR 




34 4:123329362 rs17388568 EUR 
35 7:107492789 rs4510766 EUR 
36 10:101290301 rs6584283 EUR 
37 12:68500075 rs7134599 EUR 
38 16:68674788 rs6499188 EUR 
39 17:38040763 rs2872507 EUR 
40 21:40465534 rs2836878 EUR 
41 22:50435480 rs5771069 EUR 
42 1:2513216 rs734999 EUR 
43 1:8021973 rs35675666 EUR 
44 1:22698447 rs7524102 EUR 
45 2:102663628 rs2310173 EUR 
46 2:219010146 rs11676348 EUR 
47 5:10752315 rs267939 EUR 
48 5:35876274 rs3194051 EUR 
49 5:40410935 rs6451493 EUR 
50 5:158826792 rs6871626 EUR 
51 6:43795968 rs943072 EUR 
52 6:106522027 rs6911490 EUR 
53 6:138006504 rs6920220 EUR 
54 9:4981602 rs10758669 EUR 
55 9:117553249 rs4246905 EUR 
56 9:139266405 rs10781499 EUR 
57 10:35554054 rs12261843 EUR 
58 11:1874072 rs907611 EUR 
59 11:76299194 rs2155219 EUR 
60 13:27531267 rs17085007 EUR 
61 13:41013977 rs941823 EUR 
62 16:86014241 rs16940202 EUR 
63 20:62327582 rs2297441 EUR 
64 21:16817051 rs1297265 EUR 
65 21:45615023 rs2838519 EUR 
66 1:200877562 rs7554511 EUR 
67 4:180284814 rs6811556 EUR 
68 5:107834247 rs4571457 EUR 
69 7:18800413 rs11764116 EUR 




71 13:79550934 rs7319358 EUR 
72 14:29132877 rs1956388 EUR 
73 20:31718653 rs6059101 EUR 
74 6:32079567 rs17207986 EUR 
75 9:117605070 rs11554257 EUR 
76 7:98760504 rs7809799 EUR 
77 1:20227723 rs4654925 EUR 
78 1:206943968 rs3024493 EUR 
79 1:20140036 rs1317209 EUR 
80 1:67694202 rs2201841 EUR 
81 1:161472158 rs10800309 EUR 
82 2:61186829 rs13003464 EUR 
83 3:49721532 rs3197999 EUR 
84 5:583442 rs4957048 EUR 
85 7:107503441 rs4598195 EUR 
86 9:139266496 rs4077515 EUR 
87 10:101291593 rs11190140 EUR 
88 12:68504592 rs1558744 EUR 
89 17:38062196 rs2305480 EUR 
90 1:200935866 rs11584383 EUR 
91 2:200290359 rs1992950 EUR 
92 17:38051348 rs8067378 EUR 
93 21:16805220 rs1736135 EUR 
94 16:10975311 rs4781011 EUR 
95 1:161479745 rs1801274 ASN 
96 9:5213687 rs10975003 ASN 
97 7:107453103 rs2108225 ASN 
98 7:107495434 rs886774 EUR 
99 13:40505510 rs9548988 EUR 
100 3:49701983 rs9858542 EUR 
101 9:139269338 rs10781500 EUR 
102 1:20142866 rs3806308 EUR 
103 1:67725120 rs10889677 EUR 
104 12:68596661 rs2870946 EUR 
105 9:85311147 rs668853 EUR 
106 7:107479519 rs4730273 EUR 




108 7:107580839 rs2158836 EUR 
 
 
